<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
    xmlns:content="http://purl.org/rss/1.0/modules/content/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Oncology — NAEOTOM Connect</title>
        <link>https://connect.siemens-healthineers.com/de/</link>
        <pubDate>Sun, 25 Oct 2026 16:46:20 +0000</pubDate>
        <language>de</language>
            <description>Oncology — NAEOTOM Connect</description>
    <atom:link href="https://connect.siemens-healthineers.com/de/discussions/tagged/oncology/feed.rss" rel="self" type="application/rss+xml"/>
    <item>
        <title>(2025) Opitz | First assessment of photon-counting CT for virtual bronchoscopic navigation</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/520/2025-opitz-first-assessment-of-photon-counting-ct-for-virtual-bronchoscopic-navigation</link>
        <pubDate>Fri, 04 Sep 2026 06:37:24 +0000</pubDate>
        <category>Scientific publications</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">520@/de/discussions</guid>
        <description><![CDATA[<p></p><div><div><p>In <strong>40 patients</strong> (20 PCCT vs 20 BMI- and sex-matched EID-CT), PCCT successfully provided the high-resolution datasets required for <strong>virtual bronchoscopic navigation (VBN)</strong> and could be transferred into the navigation system for procedural planning. </p><p></p><p>PCCT achieved an approximately <strong>5–6× radiation-dose reduction</strong>: CTDIvol <strong>1.5 vs 8.3 mGy</strong>, DLP <strong>52.9 vs 284.0 mGy·cm</strong>, and effective dose <strong>0.8 vs 4.6 mSv (−83%)</strong>. </p><p></p><p>Despite the substantially lower dose, PCCT showed <strong>better overall image quality, greater sharpness, lower noise and higher lung SNR</strong> than conventional EID-CT. </p><p></p><p><strong>Clinical takeaway:</strong> PCCT may allow a <strong>single low-dose examination</strong> to serve both as lung-cancer-screening/follow-up CT and the high-resolution dataset for subsequent VBN planning—potentially avoiding an additional dedicated CT. </p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fpublications.ersnet.org%2Fcontent%2Ferj%2F65%2F4%2F2402476" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/WV8WKRV5MO5K\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:849609,&quot;width&quot;:1173,&quot;height&quot;:1280,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FWV8WKRV5MO5K%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1732,&quot;dateInserted&quot;:&quot;2026-09-04T06:36:18+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FWV8WKRV5MO5K%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/WV8WKRV5MO5K/image.png" alt="image.png" height="1280" width="1173" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/WV8WKRV5MO5K/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/WV8WKRV5MO5K/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/WV8WKRV5MO5K/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/WV8WKRV5MO5K/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/WV8WKRV5MO5K/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/WV8WKRV5MO5K/image.png 2000w, https://us.v-cdn.net/6038601/uploads/WV8WKRV5MO5K/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>FIGURE 1. </strong>a) Relative distribution of the radiologists' assessments regarding image quality, sharpness and noise on a Likert scale from 1 (insufficient) to 5 (very good). b) Bar chart showing the average radiation dose in radiation-sensitive thoracic organs for both computed tomography modalities, along with the corresponding radiation dose reduction factor achieved by the use of photon-counting detector computed tomography (PCCT), with a five-fold reduction benchmark indicated by a red dashed line. c) Representative axial slices of lesions obtained using the virtual navigation bronchoscopy protocol, with energy-integrating detector computed tomography (EID-CT) (top) and PCCT (bottom) shown for different subjects. Lesions are located in the right upper lobe (left column) and the right lower lobe (right column), emphasising improved image quality, enhanced sharpness and reduced noise, as assessed by radiologists.</p><p></p><p><strong>Source:</strong> Opitz M, Funke F, Darwiche K, <em>et al.</em> First assessment of photon-counting CT for virtual bronchoscopic navigation. <em>Eur Respir J.</em> 2025;65(4):2402476. doi:10.1183/13993003.02476-2024.</p>]]>
        </description>
    </item>
    <item>
        <title>(2024) Dettmer | Chest X-ray–dose PCCT changes diagnosis in suspected pneumonia</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/519/2024-dettmer-chest-x-ray-dose-pcct-changes-diagnosis-in-suspected-pneumonia</link>
        <pubDate>Fri, 04 Sep 2026 06:34:23 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">519@/de/discussions</guid>
        <description><![CDATA[<div><div><p>In <strong>27 adults with suspected respiratory infection</strong>, an ultra-low-dose PCCT chest protocol achieved a mean effective dose of <strong>0.11 ± 0.04 mSv</strong>, essentially matching the German reference dose for a two-view chest radiograph. Despite this very low exposure, PCCT provided substantially more diagnostic information than radiography. </p><p></p><p>PCCT <strong>changed the main diagnosis in 11/27 patients (41%)</strong> and <strong>changed therapy in 10/27 (37%)</strong>. It detected previously occult infiltrates in 5 patients, confidently excluded an infiltrate in 10, and provided clinically relevant additional findings in 4. </p><p></p><p>The approach appears most useful when radiography is equivocal or clinical suspicion remains high, particularly in immunosuppressed patients. It is not a complete substitute for standard contrast-enhanced CT: <strong>2/27 patients required an additional CT</strong> for suspected pulmonary embolism or pleural empyema. </p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fkarger.com%2Fres%2Farticle%2F103%2F2%2F88%2F894609%2FPhoton-Counting-Computed-Tomography-with-the" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/JKQ9N8ICB5GD\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:2130691,&quot;width&quot;:900,&quot;height&quot;:2162,&quot;displaySize&quot;:&quot;small&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJKQ9N8ICB5GD%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1731,&quot;dateInserted&quot;:&quot;2026-09-04T06:33:33+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJKQ9N8ICB5GD%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/JKQ9N8ICB5GD/image.png" alt="image.png" height="2162" width="900" data-display-size="small" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/JKQ9N8ICB5GD/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/JKQ9N8ICB5GD/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/JKQ9N8ICB5GD/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/JKQ9N8ICB5GD/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/JKQ9N8ICB5GD/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/JKQ9N8ICB5GD/image.png 2000w, https://us.v-cdn.net/6038601/uploads/JKQ9N8ICB5GD/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1. </strong>Comparison of CXR and ULD-CT in 6 patients of our study cohort demonstrating the clinical significance and the limitations of ULD-CT. <strong>a</strong>, <strong>b</strong> Consolidation in the right lower lobe, occult in the CXR hidden behind the right diaphragm. <strong>c</strong>, <strong>d</strong> Bilateral opacities, occult in the CXR due to the low density. <strong>e</strong>, <strong>f</strong> Bilateral opacities in the CXR; the ULD-CT shows the pattern of an organizing pneumonia as additional information. <strong>g</strong>, <strong>h</strong> Bilateral opacities in the CXR; the ULD-CT shows the pattern of sarcoidosis as additional information. <strong>i</strong>, <strong>j</strong> Bilateral opacities in the CXR; the ULD-CT shows pleural masses. <strong>k</strong>, <strong>l</strong> Basal opacities in CXR and consolidation and pleural effusion in ULD-CT; for the diagnosis of a pleural empyema, the ULD-CT was not sufficient and a standard CT with contrast was needed. </p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Chest</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>Ultra-low-dose PCCT</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Unenhanced</p></td></tr><tr><td><p><strong>Breathing</strong></p></td><td><p>Full inspiration</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>100</p></td></tr><tr><td><p><strong>Spectral shaping</strong></p></td><td><p>Tin filtration</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>3</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>Flash</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>2</p></td></tr><tr><td><p><strong>Table speed [mm/s]</strong></p></td><td><p>461</p></td></tr><tr><td><p><strong>Scan time</strong></p></td><td><p>&lt;1 s for whole chest</p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p>512 × 512</p></td></tr><tr><td><p><strong>Reconstruction slice thickness [mm]</strong></p></td><td><p>1.0</p></td></tr><tr><td><p><strong>Reconstruction increment [mm]</strong></p></td><td><p>0.7</p></td></tr><tr><td><p><strong>Kernel</strong></p></td><td><p>BR40</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>Strength 2</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>0.19 ± 0.05</p></td></tr><tr><td><p><strong>DLP [mGy·cm]</strong></p></td><td><p>6.3 ± 2.1</p></td></tr><tr><td><p><strong>Effective dose [mSv]</strong></p></td><td><p>0.11 ± 0.04</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>27 patients</strong>; median age 68 years; 59% immunosuppressed</p></td></tr><tr><td><p><strong>Mean effective PCCT dose</strong></p></td><td><p><strong>0.11 ± 0.04 mSv</strong></p></td></tr><tr><td><p><strong>Occult infiltrate detected</strong></p></td><td><p><strong>5/27 (19%)</strong></p></td></tr><tr><td><p><strong>Infiltrate confidently excluded</strong></p></td><td><p><strong>10/27 (37%)</strong></p></td></tr><tr><td><p><strong>Main diagnosis changed</strong></p></td><td><p><strong>11/27 (41%)</strong></p></td></tr><tr><td><p><strong>Therapy changed</strong></p></td><td><p><strong>10/27 (37%)</strong></p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Dettmer S, Werncke T, Nikolova Mitkovska V, Brod T, Joean O, Vogel-Claussen J, Wacker F, Welte T, Rademacher J. <em>Photon Counting Computed Tomography with the Radiation Dose of a Chest X-Ray: Feasibility and Diagnostic Yield.</em> <strong>Respiration.</strong> 2024;103(2):88–94. doi:10.1159/000536065.</p>]]>
        </description>
    </item>
    <item>
        <title>(2022) Lennartz | Virtual unenhanced images show limitations for adrenal adenoma characterization</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/486/2022-lennartz-virtual-unenhanced-images-show-limitations-for-adrenal-adenoma-characterization</link>
        <pubDate>Thu, 27 Aug 2026 17:27:06 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">486@/de/discussions</guid>
        <description><![CDATA[<div><div><p>PCCT-derived virtual unenhanced (VUE) images showed no significant difference in mean attenuation compared with true unenhanced (TUE) images for adrenal adenomas (9.2 ± 8.6 HU vs 7.3 ± 8.4 HU; P = .07).</p><p><br />
Despite similar mean values, individual VUE measurements showed both over- and underestimation, resulting in 10 of 36 adrenal adenomas being misclassified when the conventional 10-HU threshold was applied to VUE images.</p><p><br />
Material decomposition was tissue dependent: VUE underestimated attenuation in muscle and the portal vein while overestimating fat attenuation, indicating that further technical optimization is required before VUE can reliably replace TUE imaging for adrenal adenoma assessment.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fpubs.rsna.org%2Fdoi%2F10.1148%2Fradiol.220919" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/JQ64337ELDFY\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1288466,&quot;width&quot;:2000,&quot;height&quot;:1150,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJQ64337ELDFY%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1656,&quot;dateInserted&quot;:&quot;2026-08-27T17:25:46+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJQ64337ELDFY%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/JQ64337ELDFY/image.png" alt="image.png" height="1150" width="2000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/JQ64337ELDFY/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/JQ64337ELDFY/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/JQ64337ELDFY/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/JQ64337ELDFY/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/JQ64337ELDFY/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/JQ64337ELDFY/image.png 2000w, https://us.v-cdn.net/6038601/uploads/JQ64337ELDFY/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 2. </strong>Case examples for photon-counting detector CT–derived images in adrenal adenoma. Left column: Axial true unenhanced (TUE) images. Middle column: Virtual unenhanced (VUE) images. Right column: Corresponding contrast-enhanced portal venous phase images. (A–C) Images in a 79-year-old woman with lipid-rich adenoma of the left adrenal gland. VUE images led to overestimation of adrenal gland attenuation, which hampered correct classification as lipid-rich adenoma using the 10-HU threshold. (D–F) Images in a 65-year-old woman with lipid-rich adenoma in the left adrenal gland. Classification based on VUE images was in concordance with classification based on TUE images, albeit with a slight overestimation of attenuation on VUE images. (G–I) Images in a 79-year-old woman with lipid-poor adenoma in the left adrenal gland show high contrast material enhancement. VUE images led to 12-HU underestimation when compared with TUE attenuation, which would still result in the correct classification.</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Abdomen / adrenal glands</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>True unenhanced + portal venous phase</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>QunatumPlus</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>Effective mAs [mAs]</strong></p></td><td><p>Automated exposure control</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>170</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>0.8</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.25–0.5</p></td></tr><tr><td><p><strong>Detector slice collimation</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Slice thickness</strong></p></td><td><p>2 mm</p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p>512 × 512</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 4</p></td></tr><tr><td><p><strong>Reconstruction</strong></p></td><td><p>Axial</p></td></tr><tr><td><p><strong>Material decomposition</strong></p></td><td><p>VUE reconstructed from portal venous phase</p></td></tr><tr><td><p><strong>Contrast agent</strong></p></td><td><p>Accupaque 300</p></td></tr><tr><td><p><strong>Contrast phase</strong></p></td><td><p>Portal venous</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p>29 patients, 36 adrenal adenomas</p></td></tr><tr><td><p><strong>VUE vs TUE attenuation</strong></p></td><td><p>9.2 ± 8.6 vs 7.3 ± 8.4 HU; <strong>P = .07</strong></p></td></tr><tr><td><p><strong>10-HU classification</strong></p></td><td><p><strong>10/36 adenomas misclassified</strong> using VUE</p></td></tr><tr><td><p><strong>Lipid-rich adenomas</strong></p></td><td><p>23/36</p></td></tr><tr><td><p><strong>Lipid-poor adenomas</strong></p></td><td><p>13/36</p></td></tr><tr><td><p><strong>Tissue dependence</strong></p></td><td><p>VUE underestimated muscle/portal vein and overestimated fat attenuation</p></td></tr><tr><td><p><strong>Clinical implication</strong></p></td><td><p>VUE cannot yet reliably substitute for TUE when applying the conventional 10-HU threshold</p></td></tr></table></div><p><strong>Source:</strong> Lennartz S, Schoenbeck D, Kröger JR, Borggrefe J, Niehoff JH. <em>Photon-counting CT Material Decomposition: Initial Experience in Assessing Adrenal Adenoma.</em> Radiology. 2023;306(1):202–204. doi:10.1148/radiol.220919. </p>]]>
        </description>
    </item>
    <item>
        <title>(2023) Schade | Pseudoenhancement of renal cysts on PCCT</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/495/2023-schade-pseudoenhancement-of-renal-cysts-on-pcct</link>
        <pubDate>Fri, 28 Aug 2026 10:10:05 +0000</pubDate>
        <category>Scientific publications</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">495@/de/discussions</guid>
        <description><![CDATA[<div><div><p>In 86 patients with 160 non-enhancing renal cysts, the study assessed how PCCT virtual monoenergetic image (VMI) energy level affects apparent renal cyst enhancement and therefore lesion classification.</p><p><br />
Low-keV VMI substantially increased apparent cyst attenuation: mean attenuation rose from 4 ± 11 HU at 190 keV to 36 ± 17 HU at 40 keV.</p><p><br />
This produced marked pseudoenhancement at low energies: at 40 keV, 35% of cysts appeared equivocally enhancing and 46% definitely enhancing; at 50 keV, these rates were 29% and 10%, respectively. At 60 keV, 9% were equivocal but none definitely enhancing.</p><p><br />
Importantly, no cyst was classified as enhancing at 70–190 keV, indicating that ≥70-keV VMI provides substantially more reliable assessment of true renal cyst enhancement.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.academicradiology.org%2Farticle%2FS1076-6332%2823%2900187-3%2Fabstract" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><p><strong>Practical PCCT takeaway: </strong></p><p>Low-keV reconstructions are attractive for increasing iodine conspicuity, but they should not be used uncritically for HU-based renal lesion characterization. For renal cyst enhancement, 70 keV appears to be a safer reference reconstruction in this study.</p><p>The observed misclassification was not significantly dependent on cyst size, location, or patient BMI, suggesting that the VMI energy itself is the dominant issue.</p><p><strong>Protocol:</strong> </p><p>Clinical PCCT, 120 kVp, image-quality level 68; triphasic examination. Venous-phase VMIs were reconstructed from 40–190 keV in 10-keV increments. Only cysts ≥7 mm confirmed as non-enhancing (&lt;10 HU difference between unenhanced and venous 70-keV images) were analyzed.</p><p>Source: Schade KA, Mergen V, Sartoretti T, Alkadhi H, Euler A. Pseudoenhancement in Cystic Renal Lesions – Impact of Virtual Monoenergetic Images of Photon-Counting Detector CT on Lesion Classification. Academic Radiology. 2023;30(Suppl 1):S305-S313. doi:10.1016/j.acra.2023.04.005. Published online May 5, 2023.</p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Huang | UHR PCCT with low-keV improves preoperative pancreatic cancer assessment</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/489/2026-huang-uhr-pcct-with-low-kev-improves-preoperative-pancreatic-cancer-assessment</link>
        <pubDate>Fri, 28 Aug 2026 06:11:40 +0000</pubDate>
        <category>Scientific publications</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">489@/de/discussions</guid>
        <description><![CDATA[<div><div><p>Combining UHR PCCT with low-keV virtual monoenergetic imaging (VMI) improved visualization of pancreatic ductal adenocarcinoma (PDAC), peripancreatic vessels, and fine pancreatic anatomy; the study identified 0.4-mm slices at 45 keV as the best overall reconstruction strategy for preoperative assessment.</p><p><br />
40-keV VMI produced the highest quantitative CNR and SNR for tumors and peripancreatic vessels, while 45–50 keV at 0.4-mm slice thickness achieved better qualitative visualization of fine anatomical structures, balancing spectral contrast enhancement with the high spatial resolution of PCCT.</p><p><br />
The combination of high spatial resolution and spectral information from PCCT may improve tumor–vessel delineation and visualization of fine structures relevant to PDAC staging and surgical planning, demonstrating the complementary value of UHR acquisition and spectral reconstruction in abdominal oncology imaging.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fabs%2Fpii%2FS0720048X25006825" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/8141ZA56ZYWA\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:298224,&quot;width&quot;:550,&quot;height&quot;:550,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F8141ZA56ZYWA%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1659,&quot;dateInserted&quot;:&quot;2026-08-28T06:10:50+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F8141ZA56ZYWA%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/8141ZA56ZYWA/image.png" alt="image.png" height="550" width="550" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/8141ZA56ZYWA/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/8141ZA56ZYWA/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/8141ZA56ZYWA/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/8141ZA56ZYWA/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/8141ZA56ZYWA/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/8141ZA56ZYWA/image.png 2000w, https://us.v-cdn.net/6038601/uploads/8141ZA56ZYWA/image.png" sizes="100vw" /></a>
    </span>
</span>
<p>Image taken from LinkedIn:</p><p>→ <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Flnkd.in%2Fp%2FdHEn3v4q" target="_blank" rel="nofollow noopener ugc">Go to post</a></p><p>Source: Huang R, Yang Y, Gao M, et al. Eur J Radiol. 2026;195:112596.</p>]]>
        </description>
    </item>
    <item>
        <title>(2022) Mergen | Virtual noncontrast abdominal imaging with PCCT</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/487/2022-mergen-virtual-noncontrast-abdominal-imaging-with-pcct</link>
        <pubDate>Thu, 27 Aug 2026 17:36:07 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">487@/de/discussions</guid>
        <description><![CDATA[<div><div><p>Virtual noncontrast (VNC) images reconstructed from contrast-enhanced PCCT provided accurate abdominal attenuation values compared with true noncontrast (TNC) imaging, supporting the potential to omit a separate TNC acquisition.</p><p><br />
Across all measurements, VNC attenuation errors were &lt;5 HU in 76% and &lt;10 HU in 95%; there was no meaningful overall difference between VNC reconstructed from arterial versus portal venous acquisitions.</p><p><br />
VNC had inferior image quality and higher/blotchier noise than TNC, but remained diagnostically usable in 99–100% of patients.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fpubs.rsna.org%2Fdoi%2F10.1148%2Fradiol.213260" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/FZEKUMKR08AW\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1376583,&quot;width&quot;:2000,&quot;height&quot;:1150,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FFZEKUMKR08AW%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1657,&quot;dateInserted&quot;:&quot;2026-08-27T17:35:43+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FFZEKUMKR08AW%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/FZEKUMKR08AW/image.png" alt="image.png" height="1150" width="2000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/FZEKUMKR08AW/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/FZEKUMKR08AW/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/FZEKUMKR08AW/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/FZEKUMKR08AW/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/FZEKUMKR08AW/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/FZEKUMKR08AW/image.png 2000w, https://us.v-cdn.net/6038601/uploads/FZEKUMKR08AW/image.png" sizes="100vw" /></a>
    </span>
</span>
<p>Figure 2: CT attenuation measurements in a 58-year-old man referred for follow-up examination after an acute type B aortic dissection. Axial CT images acquired with photon-counting detector CT depict exemplary region-of-interest (ROI) measurements on venous virtual noncontrast reconstructions. avg = average attenuation within region of interest; d = diameter of region of interest.</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Detector</strong></p></td><td><p>Dual-source, two cadmium telluride PCDs</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Thoracoabdominal</p></td></tr><tr><td><p><strong>Scan phases</strong></p></td><td><p>TNC + arterial + portal venous</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>Single-source multienergy, <strong>QuantumPlus</strong></p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>Tube current</strong></p></td><td><p>Automated modulation, CARE Dose4D / CARE kV</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>68</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.25</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>1.2</p></td></tr><tr><td><p><strong>Detector slice collimation</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>70 mL iopromide, 370 mg I/mL</p></td></tr><tr><td><p><strong>Injection rate</strong></p></td><td><p>4 mL/s</p></td></tr><tr><td><p><strong>Arterial timing</strong></p></td><td><p>Bolus tracking; 140 HU threshold at 90 kV + 12-s delay</p></td></tr><tr><td><p><strong>Portal venous timing</strong></p></td><td><p>70 s after contrast injection</p></td></tr><tr><td><p><strong>Reconstruction kernel</strong></p></td><td><p>Br36</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 4</p></td></tr><tr><td><p><strong>Slice thickness [mm]</strong></p></td><td><p>2.0</p></td></tr><tr><td><p><strong>Reconstruction increment [mm]</strong></p></td><td><p>1.6</p></td></tr><tr><td><p><strong>Reconstruction plane</strong></p></td><td><p>Axial</p></td></tr><tr><td><p><strong>VNC source phases</strong></p></td><td><p>Arterial and portal venous</p></td></tr><tr><td><p><strong>Reference standard</strong></p></td><td><p>True noncontrast (TNC) images</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p>100 patients; mean age 72 ± 10 years; 81 men</p></td></tr><tr><td><p><strong>Overall VNC error &lt;5 HU</strong></p></td><td><p><strong>76%</strong> of measurements</p></td></tr><tr><td><p><strong>Overall VNC error &lt;10 HU</strong></p></td><td><p><strong>95%</strong> of measurements</p></td></tr><tr><td><p><strong>Arterial vs venous VNC error</strong></p></td><td><p>3.3 vs 3.5 HU; <strong>P = .16</strong></p></td></tr><tr><td><p><strong>Left liver attenuation error</strong></p></td><td><p><strong>1.4 ± 1.3 HU arterial VNC; 1.5 ± 1.2 HU venous VNC</strong></p></td></tr><tr><td><p><strong>Liver error &lt;5 HU</strong></p></td><td><p>Left lobe <strong>99%</strong>; right lobe <strong>98%</strong> for both arterial and venous VNC</p></td></tr><tr><td><p><strong>Diagnostic subjective quality</strong></p></td><td><p><strong>99–100%</strong></p></td></tr><tr><td><p><strong>VNC noise</strong></p></td><td><p><strong>33% higher</strong> than TNC in phantom</p></td></tr><tr><td><p><strong>Noise texture</strong></p></td><td><p>VNC more blotchy; average spatial frequency <strong>0.14 vs 0.20 mm⁻¹</strong></p></td></tr><tr><td><p><strong>Spatial resolution</strong></p></td><td><p>Similar overall; TTF50 <strong>0.29 mm⁻¹</strong> for both</p></td></tr><tr><td><p><strong>Detectability index</strong></p></td><td><p>VNC approximately <strong>15% lower</strong>, but always <strong>&gt;20</strong></p></td></tr></table></div><p>The liver showed particularly small VNC attenuation errors, with left-lobe mean errors around <strong>1.5 HU</strong>.  Phantom testing confirmed higher and blotchier VNC noise but similar middle-frequency spatial resolution and a detectability index consistently above 20. </p><p><strong>Take-home:</strong> PCCT VNC can provide quantitatively accurate abdominal attenuation without a dedicated noncontrast acquisition. The principal trade-off is higher, blotchier image noise and somewhat poorer subjective image quality, although diagnostic quality remained very high. </p><p><strong>Source:</strong> Mergen V, Racine D, Jungblut L, et al. <em>Virtual Noncontrast Abdominal Imaging with Photon-counting Detector CT.</em> <strong>Radiology.</strong> 2022;305(1):107–115. doi:10.1148/radiol.213260.</p>]]>
        </description>
    </item>
    <item>
        <title>(2024) Khanungwanitkul | PCCT reveals pancreatic duct connection of a side-branch IPMN</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/485/2024-khanungwanitkul-pcct-reveals-pancreatic-duct-connection-of-a-side-branch-ipmn</link>
        <pubDate>Thu, 27 Aug 2026 17:21:38 +0000</pubDate>
        <category>Case reports</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">485@/de/discussions</guid>
        <description><![CDATA[<p></p><div><div><p>This case report has been published in Radiology.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fpubs.rsna.org%2Fdoi%2F10.1148%2Fradiol.240611" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/ZKHKE0BYCA7L\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:2213773,&quot;width&quot;:2000,&quot;height&quot;:1150,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FZKHKE0BYCA7L%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1653,&quot;dateInserted&quot;:&quot;2026-08-27T17:18:09+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FZKHKE0BYCA7L%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/ZKHKE0BYCA7L/image.png" alt="image.png" height="1150" width="2000" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/ZKHKE0BYCA7L/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/ZKHKE0BYCA7L/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/ZKHKE0BYCA7L/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/ZKHKE0BYCA7L/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/ZKHKE0BYCA7L/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/ZKHKE0BYCA7L/image.png 2000w, https://us.v-cdn.net/6038601/uploads/ZKHKE0BYCA7L/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1.</strong> Axial photon-counting CT images at (A) 0.4-mm, (C) 2-mm, and (D) 4-mm section thickness demonstrate an incidental hypoattenuating pancreatic lesion (arrowhead). The lesion communicates with the main pancreatic duct via a connection (arrow) visible at 0.4-mm section thickness. (B) Iodine overlay image at 0.4-mm section thickness displays iodine content in orange, demonstrating no uptake within the hypoattenuating lesion or main duct communication.</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/LQW7C1SVL1FR\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:890475,&quot;width&quot;:1000,&quot;height&quot;:734,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FLQW7C1SVL1FR%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1654,&quot;dateInserted&quot;:&quot;2026-08-27T17:20:43+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FLQW7C1SVL1FR%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/LQW7C1SVL1FR/image.png" alt="image.png" height="734" width="1000" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/LQW7C1SVL1FR/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/LQW7C1SVL1FR/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/LQW7C1SVL1FR/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/LQW7C1SVL1FR/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/LQW7C1SVL1FR/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/LQW7C1SVL1FR/image.png 2000w, https://us.v-cdn.net/6038601/uploads/LQW7C1SVL1FR/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 2. </strong>Coronal cinematic rendering of the intraductal papillary mucinous neoplasm (arrowhead) in relation to the pancreatic duct</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/66LNHAX8GXFA\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:425785,&quot;width&quot;:999,&quot;height&quot;:784,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F66LNHAX8GXFA%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1655,&quot;dateInserted&quot;:&quot;2026-08-27T17:21:00+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F66LNHAX8GXFA%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/66LNHAX8GXFA/image.png" alt="image.png" height="784" width="999" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/66LNHAX8GXFA/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/66LNHAX8GXFA/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/66LNHAX8GXFA/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/66LNHAX8GXFA/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/66LNHAX8GXFA/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/66LNHAX8GXFA/image.png 2000w, https://us.v-cdn.net/6038601/uploads/66LNHAX8GXFA/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 3.</strong> Axial T2-weighted image at 5-mm section thickness from MR cholangiopancreatography confirms the cystic nature of the lesion (arrow) but does not show the connection to the main pancreatic duct.</p><p>Source: Khanungwanitkul K, Schwartz FR. Photon-Counting CT Shows Side-Branch Intraductal Papillary Mucinous Neoplasm–Pancreatic Duct Connection. Radiology. 2024;312(2). doi:10.1148/radiol.240611.</p>]]>
        </description>
    </item>
    <item>
        <title>(2023) Graafen | Soft Reconstruction Kernels Improve HCC Imaging on a PCCT</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/473/2023-graafen-soft-reconstruction-kernels-improve-hcc-imaging-on-a-pcct</link>
        <pubDate>Sat, 08 Aug 2026 07:00:52 +0000</pubDate>
        <category>Scientific publications</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">473@/de/discussions</guid>
        <description><![CDATA[<div><div><p>In a phantom and clinical study involving 24 patients with viable hepatocellular carcinoma (HCC), Graafen et al. evaluated reconstruction kernels for triple-phase photon-counting detector CT (PCD-CT), using 50-keV virtual monoenergetic images. Image quality was assessed quantitatively through contrast-to-noise ratio (CNR) and edge sharpness and qualitatively by three readers.</p><p></p><p>The softest reconstruction kernels (sharpness level 36) produced the highest CNR across all contrast phases (all p &lt; 0.05) without significantly reducing lesion sharpness. Softer kernels were also rated significantly better for image noise and overall image quality, although image contrast and HCC lesion conspicuity did not significantly differ between kernels. There was also no meaningful image-quality difference between regular body and quantitative kernels at equivalent sharpness levels.</p><p></p><p>Bottom line: For HCC assessment with photon-counting CT, soft reconstruction kernels provide the best overall image quality. The authors specifically recommend quantitative soft kernels, because they maintain comparable image quality while preserving the possibility of subsequent spectral post-processing.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.academicradiology.org%2Farticle%2FS1076-6332%2823%2900162-9%2Fabstract" rel="nofollow noopener ugc" role="button">Access publication</a></p><p>Source: Graafen D, Müller L, Halfmann MC, et al. Soft Reconstruction Kernels Improve HCC Imaging on a Photon-Counting Detector CT. Academic Radiology. 2023;30(Suppl 1):S143–S154. doi:10.1016/j.acra.2023.03.026.</p>]]>
        </description>
    </item>
    <item>
        <title>(2024) Bette | PCCT virtual non-contrast imaging differentiates adrenal adenomas from metastases</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/469/2024-bette-pcct-virtual-non-contrast-imaging-differentiates-adrenal-adenomas-from-metastases</link>
        <pubDate>Sat, 08 Aug 2026 06:39:31 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">469@/de/discussions</guid>
        <description><![CDATA[<div><div><p><strong>PCCT virtual non-contrast (VNC) reconstructions</strong> differentiated adrenal adenomas from metastases on portal-venous contrast-enhanced imaging, with adenomas showing significantly lower attenuation on both conventional VNC (VNCConv) and calcium-preserving PureCalcium VNC (VNCPC) (<em>p</em> = 0.007). </p><p></p><p>VNC nevertheless <strong>systematically overestimated attenuation compared with true non-contrast (TNC)</strong> imaging: mean differences were <strong>17.67 HU for VNCConv</strong> and <strong>14.85 HU for VNCPC</strong>, indicating that the conventional <strong>10-HU TNC threshold cannot simply be transferred to PCCT VNC</strong>. </p><p></p><p>Diagnostic performance was particularly strong for <strong>VNCPC (AUC 0.931)</strong> and when combining all available spectral information (<strong>AUC 0.938</strong>). For VNCConv, a higher threshold of <strong>26 HU</strong> achieved <strong>86.7% sensitivity and 75.6% specificity</strong>, supporting a PCCT-specific VNC threshold for adrenal lesion characterization. </p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00330-024-10675-x" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/87WR1SDBK0XA\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1461715,&quot;width&quot;:1415,&quot;height&quot;:1064,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F87WR1SDBK0XA%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1615,&quot;dateInserted&quot;:&quot;2026-08-08T06:38:26+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F87WR1SDBK0XA%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/87WR1SDBK0XA/image.png" alt="image.png" height="1064" width="1415" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/87WR1SDBK0XA/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/87WR1SDBK0XA/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/87WR1SDBK0XA/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/87WR1SDBK0XA/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/87WR1SDBK0XA/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/87WR1SDBK0XA/image.png 2000w, https://us.v-cdn.net/6038601/uploads/87WR1SDBK0XA/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1.</strong> Example of semiautomatic segmentation of a left adrenal adenoma using 3D Slicer.</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Application</strong></p></td><td><p>Contrast-enhanced abdominal CT / adrenal lesion characterization</p></td></tr><tr><td><p><strong>Study design</strong></p></td><td><p>Retrospective, single-center</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>Abdomen QuantumPlus with spectral information</p></td></tr><tr><td><p><strong>Contrast phase</strong></p></td><td><p>Portal venous</p></td></tr><tr><td><p><strong>Scan direction</strong></p></td><td><p>Craniocaudal</p></td></tr><tr><td><p><strong>Patient position</strong></p></td><td><p>Supine</p></td></tr><tr><td><p><strong>Breath-hold</strong></p></td><td><p>Single breath-hold</p></td></tr><tr><td><p><strong>Tube voltage</strong></p></td><td><p>120 kV</p></td></tr><tr><td><p><strong>Rotation time</strong></p></td><td><p>0.5 s or 0.25 s</p></td></tr><tr><td><p><strong>Collimation</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Slice thickness</strong></p></td><td><p>1.0 mm</p></td></tr><tr><td><p><strong>Reconstruction increment</strong></p></td><td><p>0.5 mm</p></td></tr><tr><td><p><strong>Reconstruction kernel</strong></p></td><td><p>Qr40</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 3</p></td></tr><tr><td><p><strong>Reconstruction software</strong></p></td><td><p>ReconCT 16.0</p></td></tr><tr><td><p><strong>TNC reconstruction software</strong></p></td><td><p>Syngo.via VB60A</p></td></tr><tr><td><p><strong>VNC reconstructions</strong></p></td><td><p>Conventional VNC (VNCConv) and PureCalcium VNC (VNCPC)</p></td></tr><tr><td><p><strong>VNC energy</strong></p></td><td><p>70 keV</p></td></tr><tr><td><p><strong>Virtual monoenergetic images</strong></p></td><td><p>40–90 keV in 10-keV increments</p></td></tr><tr><td><p><strong>Additional spectral reconstruction</strong></p></td><td><p>Iodine maps</p></td></tr><tr><td><p><strong>Contrast agent</strong></p></td><td><p>Ultravist 300 mg I/mL</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>100 mL</p></td></tr><tr><td><p><strong>Flow rate</strong></p></td><td><p>4.0 mL/s</p></td></tr><tr><td><p><strong>Saline chaser</strong></p></td><td><p>30 mL</p></td></tr><tr><td><p><strong>Scan delay</strong></p></td><td><p>Fixed 75 s after contrast injection</p></td></tr><tr><td><p><strong>True non-contrast imaging</strong></p></td><td><p>Available in 49/90 patients; obtained either within the same protocol or from a separate CT acquisition</p></td></tr><tr><td><p><strong>Lesion analysis</strong></p></td><td><p>Semiautomatic whole-lesion 3D segmentation</p></td></tr><tr><td><p><strong>Segmentation software</strong></p></td><td><p>3D Slicer</p></td></tr><tr><td><p><strong>Primary comparison</strong></p></td><td><p>VNCConv and VNCPC vs TNC; spectral imaging for adenoma vs metastasis differentiation</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Parameter</p></th><th><p>Main finding</p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p>90 patients; 45 adrenal adenomas and 45 metastases</p></td></tr><tr><td><p><strong>VNCConv attenuation</strong></p></td><td><p>Adenomas <strong>18.15 HU [12.92–24.26]</strong> vs metastases <strong>31.28 HU [26.00–35.89]</strong>; <em>p</em> = 0.007</p></td></tr><tr><td><p><strong>VNCPC attenuation</strong></p></td><td><p>Adenomas <strong>16.00 HU [11.02–21.56]</strong> vs metastases <strong>27.22 HU [22.59–30.64]</strong>; <em>p</em> = 0.007</p></td></tr><tr><td><p><strong>VNCConv vs TNC</strong></p></td><td><p>VNCConv overestimated attenuation by a mean <strong>17.67 HU</strong></p></td></tr><tr><td><p><strong>VNCPC vs TNC</strong></p></td><td><p>VNCPC overestimated attenuation by a mean <strong>14.85 HU</strong></p></td></tr><tr><td><p><strong>All spectral features</strong></p></td><td><p><strong>AUC 0.938</strong> for adenoma/metastasis discrimination</p></td></tr><tr><td><p><strong>VNCPC alone</strong></p></td><td><p><strong>AUC 0.931</strong></p></td></tr><tr><td><p><strong>VNCConv alone</strong></p></td><td><p><strong>AUC 0.857</strong></p></td></tr><tr><td><p><strong>TNC alone</strong></p></td><td><p><strong>AUC 0.762</strong></p></td></tr><tr><td><p><strong>VNCConv 26-HU cutoff</strong></p></td><td><p><strong>86.7% sensitivity, 75.6% specificity</strong></p></td></tr><tr><td><p><strong>Feature importance</strong></p></td><td><p>VNCConv and VNCPC were the most important discriminators in random-forest feature selection</p></td></tr><tr><td><p><strong>Main implication</strong></p></td><td><p>PCCT VNC may enable adrenal lesion characterization from contrast-enhanced scans, potentially reducing additional dedicated adrenal CT/MRI examinations, but requires a <strong>higher VNC-specific HU threshold</strong> rather than direct application of the conventional 10-HU TNC cutoff.</p></td></tr></table></div><p><strong>Source:</strong><br />
Bette S, Risch F, Canalini L, Becker J, Leithner EV, Huber A, Haerting M, Jehs B, Wollny C, Schwarz F, Tehlan K, Scheurig-Muenkler C, Wendler T, Kroencke T, Decker JA. <em>Diagnostic performance of photon-counting detector CT for differentiation between adrenal adenomas and metastases.</em> European Radiology. 2024;34:5944–5953. </p>]]>
        </description>
    </item>
    <item>
        <title>(2022) Bette | Low-keV PCCT improves conspicuity of hypovascularized liver metastases</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/468/2022-bette-low-kev-pcct-improves-conspicuity-of-hypovascularized-liver-metastases</link>
        <pubDate>Sat, 08 Aug 2026 06:35:12 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">468@/de/discussions</guid>
        <description><![CDATA[<p></p><div><div><p><strong>PCCT virtual monoenergetic imaging (VMI)</strong> improved visualization of hypovascularized liver metastases, with the greatest lesion conspicuity and CNR achieved at the <strong>low end of the keV spectrum</strong>. At 40 keV, tumor-to-liver ratio (TLR) reached <strong>0.37</strong>, while CNR peaked at <strong>6.88</strong>.</p><p></p><p>Compared with conventional EID-CT, PCCT showed <strong>lower image noise at 70 keV</strong> (15.4 vs. 17.1 HU), while VMI below 70 keV produced higher lesion CNR and greater tumor-to-liver contrast.</p><p></p><p>The advantage was particularly relevant in patients with <strong>higher BMI</strong>: around the clinically relevant 60–80 keV range, PCCT maintained image noise and largely preserved CNR despite a more moderate CTDI upregulation than EID-CT. </p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.mdpi.com%2F2075-4418%2F12%2F5%2F1231" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/MTIQ6E0CDSOK\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:3095899,&quot;width&quot;:3000,&quot;height&quot;:1725,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FMTIQ6E0CDSOK%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1614,&quot;dateInserted&quot;:&quot;2026-08-08T06:34:08+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FMTIQ6E0CDSOK%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/MTIQ6E0CDSOK/image.png" alt="image.png" height="1725" width="3000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/MTIQ6E0CDSOK/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/MTIQ6E0CDSOK/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/MTIQ6E0CDSOK/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/MTIQ6E0CDSOK/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/MTIQ6E0CDSOK/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/MTIQ6E0CDSOK/image.png 2000w, https://us.v-cdn.net/6038601/uploads/MTIQ6E0CDSOK/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 4.</strong> Example of PCD-VMIs (40–190 keV) in a patient with hypovascularized liver metastases of pleura mesothelioma. Hypovascularized metastasis in segment VI (arrow). </p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p><strong>Scanner (PCCT)</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scanner (EID-CT)</strong></p></td><td><p>SOMATOM AS20</p></td></tr><tr><td><p><strong>Application</strong></p></td><td><p>Contrast-enhanced abdominal oncologic CT; hypovascularized liver metastases</p></td></tr><tr><td><p><strong>Study population</strong></p></td><td><p>100 patients with liver metastases: PCCT n = 50, EID-CT n = 50</p></td></tr><tr><td><p><strong>PCCT acquisition mode</strong></p></td><td><p>QuantumPlus with spectral information</p></td></tr><tr><td><p><strong>Detector energy thresholds</strong></p></td><td><p>20, 35, 65, 70 keV</p></td></tr><tr><td><p><strong>Scan direction</strong></p></td><td><p>Craniocaudal</p></td></tr><tr><td><p><strong>Patient position</strong></p></td><td><p>Supine</p></td></tr><tr><td><p><strong>Scan range</strong></p></td><td><p>Diaphragm or upper thoracic aperture to symphysis</p></td></tr><tr><td><p><strong>Breath-hold</strong></p></td><td><p>Single breath-hold</p></td></tr><tr><td><p><strong>Tube voltage (PCCT)</strong></p></td><td><p>120 kVp</p></td></tr><tr><td><p><strong>Tube current modulation</strong></p></td><td><p>CARE Dose4D</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>145</p></td></tr><tr><td><p><strong>Rotation time</strong></p></td><td><p>0.25 s</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>0.8</p></td></tr><tr><td><p><strong>Collimation</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Reconstruction kernel</strong></p></td><td><p>Qr40</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 3</p></td></tr><tr><td><p><strong>Slice thickness</strong></p></td><td><p>1.0 mm</p></td></tr><tr><td><p><strong>Reconstruction increment</strong></p></td><td><p>1.0 mm</p></td></tr><tr><td><p><strong>Spectral postprocessing</strong></p></td><td><p>SPP spectral series</p></td></tr><tr><td><p><strong>VMI levels</strong></p></td><td><p>40, 45, 50, 55, 60, 70, 80, 90, 100, 110, 130, 150, 170, 190 keV</p></td></tr><tr><td><p><strong>Contrast agent</strong></p></td><td><p>Iopromide (Ultravist 300 mg I/mL)</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>120 mL</p></td></tr><tr><td><p><strong>Saline chaser</strong></p></td><td><p>30 mL</p></td></tr><tr><td><p><strong>Flow rate</strong></p></td><td><p>4.0 mL/s</p></td></tr><tr><td><p><strong>Bolus triggering</strong></p></td><td><p>120 HU in ascending aorta</p></td></tr><tr><td><p><strong>Post-trigger delay</strong></p></td><td><p>45 s</p></td></tr><tr><td><p><strong>EID-CT tube voltage</strong></p></td><td><p>Auto-kV; 100 kVp in 46 patients, 120 kVp in 4 patients</p></td></tr><tr><td><p><strong>EID-CT rotation time</strong></p></td><td><p>0.5 s</p></td></tr><tr><td><p><strong>EID-CT pitch</strong></p></td><td><p>1.05</p></td></tr><tr><td><p><strong>EID-CT collimation</strong></p></td><td><p>1.5 × 16 × 1.2 mm</p></td></tr><tr><td><p><strong>EID-CT reconstruction</strong></p></td><td><p>I31f, SAFIRE level 3</p></td></tr><tr><td><p><strong>Primary endpoints</strong></p></td><td><p>Image noise, tumor-to-liver ratio (TLR), contrast-to-noise ratio (CNR), BMI-dependent performance</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Parameter</p></th><th><p>Main finding</p></th></tr><tr><td><p><strong>Optimal lesion conspicuity</strong></p></td><td><p>Greatest at <strong>low-keV VMI</strong>; TLR was lowest at <strong>40 keV (0.37)</strong></p></td></tr><tr><td><p><strong>CNR</strong></p></td><td><p>Maximum at the low end of the spectrum: <strong>6.88</strong>; CNR was significantly higher at ≤70 keV than &gt;70 keV</p></td></tr><tr><td><p><strong>Image noise</strong></p></td><td><p>At <strong>70 keV</strong>, PCCT had lower noise than EID-CT: <strong>15.4 vs. 17.1 HU</strong></p></td></tr><tr><td><p><strong>70-keV comparison</strong></p></td><td><p>TLR and CNR were broadly comparable between PCCT and EID-CT</p></td></tr><tr><td><p><strong>&lt;70-keV advantage</strong></p></td><td><p>PCCT provided <strong>higher CNR and greater lesion conspicuity</strong> than EID-CT</p></td></tr><tr><td><p><strong>BMI effect</strong></p></td><td><p>At 70 keV, PCCT maintained similar noise in high- vs. low-BMI patients (<strong>15.8 vs. 15.3 HU</strong>)</p></td></tr><tr><td><p><strong>Dose/BMI relationship</strong></p></td><td><p>CTDI increased with BMI on both systems, but the increase was <strong>more pronounced with EID-CT</strong></p></td></tr><tr><td><p><strong>Main implication</strong></p></td><td><p>Spectral PCCT allows low-keV VMI to increase iodine contrast and improve visualization of hypovascularized liver metastases while maintaining favorable noise characteristics, with a particular advantage in larger patients.</p></td></tr></table></div><p><strong>Source:</strong><br />
Bette S, Decker JA, Braun FM, Becker J, Haerting M, Haeckel T, Gebhard M, Risch F, Woźnicki P, Scheurig-Muenkler C, Kroencke TJ, Schwarz F. <em>Optimal Conspicuity of Liver Metastases in Virtual Monochromatic Imaging Reconstructions on a Novel Photon-Counting Detector CT—Effect of keV Settings and BMI.</em> Diagnostics. 2022;12(5):1231. doi:10.3390/diagnostics12051231.  </p>]]>
        </description>
    </item>
    <item>
        <title>(2025) Becker | Spectral PCCT differentiates hyperdense vascular from non-vascular renal lesions</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/467/2025-becker-spectral-pcct-differentiates-hyperdense-vascular-from-non-vascular-renal-lesions</link>
        <pubDate>Sat, 08 Aug 2026 06:28:57 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">467@/de/discussions</guid>
        <description><![CDATA[<div><div><p>This pilot study demonstrates that <strong>spectral information from photon-counting detector CT (PCD-CT)</strong> can help differentiate hyperdense renal cysts from vascular renal lesions when conventional portal-venous images are indeterminate. In <strong>26 patients with 42 hyperdense renal lesions</strong>, attenuation on standard <strong>70-keV VMI substantially overlapped</strong> between vascular and non-vascular lesions.</p><p></p><p><strong>Iodine quantification maps provided the strongest differentiation:</strong> non-vascular lesions measured <strong>5.7 ± 7.8 HU</strong> versus <strong>33.3 ± 19.0 HU</strong> for vascular lesions. A threshold of <strong>&gt;20.3 HU</strong> identified vascular lesions with <strong>87.5% sensitivity and 88.2% specificity</strong>, correctly identifying 7/8 vascular lesions. </p><p></p><p><strong>VNC was less specific</strong>: a 52-HU threshold achieved <strong>100% sensitivity but only 55.9% specificity</strong>. The results suggest that routinely available spectral PCD-CT data—particularly iodine maps—could potentially reduce additional true non-contrast or multiphasic imaging when an incidental hyperdense renal lesion is encountered, although validation in larger cohorts is required. </p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.mdpi.com%2F2075-4418%2F15%2F1%2F79" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/Y4URNF6JKL88\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:5828845,&quot;width&quot;:3965,&quot;height&quot;:2930,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FY4URNF6JKL88%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1613,&quot;dateInserted&quot;:&quot;2026-08-08T06:27:56+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FY4URNF6JKL88%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/Y4URNF6JKL88/image.png" alt="image.png" height="2930" width="3965" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/Y4URNF6JKL88/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/Y4URNF6JKL88/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/Y4URNF6JKL88/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/Y4URNF6JKL88/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/Y4URNF6JKL88/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/Y4URNF6JKL88/image.png 2000w, https://us.v-cdn.net/6038601/uploads/Y4URNF6JKL88/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 3.</strong> (<strong>A</strong>): Axial 70 keV reconstruction as well as VNC and iodine maps of a left renal mass in a portal venous CT scan of the abdomen. The lesion shows elevated HU in 70 keV (75 HU), VNC values of 66 HU (<strong>B</strong>) and 13 HU for iodine map CT values (<strong>C</strong>). (<strong>D</strong>,<strong>E</strong>): Contrast-enhanced ultrasound confirmed that there was no contrast medium uptake. (<strong>F</strong>–<strong>H</strong>): Example of a renal mass without solid components and elevated CT values in iodine maps in comparison to the first patient (52 HU) and similar values in 70 keV reconstructions (86 HU) compared to the confirmed renal cyst (<strong>A</strong>). Contrast-enhanced ultrasound confirmed a contrast enhancement (green arrow in (<strong>I</strong>,<strong>J</strong>)) and histopathology revealed the diagnosis of a renal cell carcinoma. </p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Application</strong></p></td><td><p>Contrast-enhanced abdominal CT / characterization of hyperdense renal lesions</p></td></tr><tr><td><p><strong>Study population</strong></p></td><td><p>26 patients, 42 hyperdense renal lesions (&gt;20 HU)</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>QuantumPlus with spectral information</p></td></tr><tr><td><p><strong>Scan phase</strong></p></td><td><p>Portal venous phase</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Lung apex or diaphragm to symphysis</p></td></tr><tr><td><p><strong>Scan direction</strong></p></td><td><p>Craniocaudal</p></td></tr><tr><td><p><strong>Patient position</strong></p></td><td><p>Supine</p></td></tr><tr><td><p><strong>Breath-hold</strong></p></td><td><p>Single breath-hold</p></td></tr><tr><td><p><strong>Tube voltage</strong></p></td><td><p>120 kVp</p></td></tr><tr><td><p><strong>Tube current modulation</strong></p></td><td><p>CARE Dose4D</p></td></tr><tr><td><p><strong>Rotation time</strong></p></td><td><p>0.25 s</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>0.8</p></td></tr><tr><td><p><strong>Collimation</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Slice thickness</strong></p></td><td><p>1.0 mm</p></td></tr><tr><td><p><strong>Reconstruction increment</strong></p></td><td><p>1.0 mm</p></td></tr><tr><td><p><strong>Reconstruction kernel</strong></p></td><td><p>Qr40</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 3</p></td></tr><tr><td><p><strong>Spectral postprocessing</strong></p></td><td><p>SPP</p></td></tr><tr><td><p><strong>VMI</strong></p></td><td><p>70 keV</p></td></tr><tr><td><p><strong>Spectral reconstructions</strong></p></td><td><p>VNC and iodine quantification maps</p></td></tr><tr><td><p><strong>Workstation</strong></p></td><td><p>Syngo.Via VB60A</p></td></tr><tr><td><p><strong>Contrast agent</strong></p></td><td><p>Iopromide (Ultravist 300 mgI/mL)</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>120 mL</p></td></tr><tr><td><p><strong>Saline chaser</strong></p></td><td><p>30 mL</p></td></tr><tr><td><p><strong>Flow rate</strong></p></td><td><p>4.0 mL/s</p></td></tr><tr><td><p><strong>Bolus triggering</strong></p></td><td><p>120 HU in ascending aorta</p></td></tr><tr><td><p><strong>Post-trigger delay</strong></p></td><td><p>45 s</p></td></tr><tr><td><p><strong>Image analysis</strong></p></td><td><p>Three ROI measurements per renal lesion; mean value used</p></td></tr><tr><td><p><strong>Reference standard</strong></p></td><td><p>TNC CT, ultrasound/CEUS, MRI/PET-CT, or histopathology</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Parameter</p></th><th><p>Main finding</p></th></tr><tr><td><p><strong>Study cohort</strong></p></td><td><p>26 patients with 42 hyperdense renal lesions</p></td></tr><tr><td><p><strong>70-keV VMI</strong></p></td><td><p>Substantial overlap between non-vascular (<strong>61.4 ± 19.4 HU</strong>) and vascular lesions (<strong>65.5 ± 17.4 HU</strong>); <em>p</em> = 1.000</p></td></tr><tr><td><p><strong>Iodine maps</strong></p></td><td><p>Non-vascular <strong>5.7 ± 7.8 HU</strong> vs vascular <strong>33.3 ± 19.0 HU</strong>; <em>p</em> = 0.002</p></td></tr><tr><td><p><strong>Iodine-map threshold</strong></p></td><td><p><strong>&gt;20.3 HU</strong></p></td></tr><tr><td><p><strong>Iodine-map performance</strong></p></td><td><p><strong>87.5% sensitivity, 88.2% specificity</strong></p></td></tr><tr><td><p><strong>Vascular lesions detected</strong></p></td><td><p><strong>7/8 (87.5%)</strong></p></td></tr><tr><td><p><strong>VNC values</strong></p></td><td><p>Non-vascular <strong>55.7 ± 24.2 HU</strong> vs vascular <strong>32.2 ± 11.1 HU</strong>; <em>p</em> = 0.034</p></td></tr><tr><td><p><strong>VNC threshold</strong></p></td><td><p><strong>52 HU</strong></p></td></tr><tr><td><p><strong>VNC performance</strong></p></td><td><p><strong>100% sensitivity, 55.9% specificity</strong></p></td></tr><tr><td><p><strong>70-keV threshold</strong></p></td><td><p><strong>74 HU</strong></p></td></tr><tr><td><p><strong>70-keV performance</strong></p></td><td><p><strong>76.5% sensitivity, 50% specificity</strong></p></td></tr><tr><td><p><strong>Best spectral feature</strong></p></td><td><p><strong>Iodine quantification maps</strong> were the most important discriminator in random-forest feature selection</p></td></tr><tr><td><p><strong>Potential implication</strong></p></td><td><p>Spectral iodine information from routine PCD-CT may reduce the need for additional TNC or follow-up examinations in indeterminate hyperdense renal lesions, pending validation in larger studies</p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Becker J, Feitelson L-M, Risch F, Canalini L, Kaufmann D, Wudy R, Jehs B, Haerting M, Wollny C, Scheurig-Muenkler C, et al. <em>Spectral Differentiation of Hyperdense Non-Vascular and Vascular Renal Lesions Without Solid Components in Contrast-Enhanced Photon-Counting Detector CT Scans—A Pilot Study.</em> Diagnostics. 2025;15(1):79. https://doi.org/10.3390/diagnostics15010079 </p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Pannenbecker | UHR PCCT pulmonary angiography improves pulmonary artery visibility/confidence</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/433/2026-pannenbecker-uhr-pcct-pulmonary-angiography-improves-pulmonary-artery-visibility-confidence</link>
        <pubDate>Fri, 26 Jun 2026 13:31:25 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">433@/de/discussions</guid>
        <description><![CDATA[<div><div><p>Ultra-high-resolution (UHR) photon-counting CT pulmonary angiography significantly improved visualization of peripheral pulmonary arteries and increased radiologists' diagnostic confidence compared with state-of-the-art dual-energy EID-CT.</p><p></p><p>UHR-PCD-CT achieved substantially higher pulmonary arterial enhancement (568–623 HU vs. 397 HU) while maintaining similar SNR and CNR, enabling superior subjective image quality and iodine map quality.</p><p></p><p>A low-dose UHR protocol (IQ25) reduced radiation dose by approximately 36% compared with EID-CT while maintaining the same image quality and diagnostic confidence as the higher-dose UHR protocol (IQ50).</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00330-026-12588-3" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/HCIQBEUOR0BQ\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:284188,&quot;width&quot;:685,&quot;height&quot;:384,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FHCIQBEUOR0BQ%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1518,&quot;dateInserted&quot;:&quot;2026-06-26T13:28:17+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FHCIQBEUOR0BQ%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/HCIQBEUOR0BQ/image.png" alt="image.png" height="384" width="685" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/HCIQBEUOR0BQ/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/HCIQBEUOR0BQ/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/HCIQBEUOR0BQ/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/HCIQBEUOR0BQ/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/HCIQBEUOR0BQ/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/HCIQBEUOR0BQ/image.png 2000w, https://us.v-cdn.net/6038601/uploads/HCIQBEUOR0BQ/image.png" sizes="100vw" /></a>
    </span>
</span>
<span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/TUBP6QYVJP3M\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:854736,&quot;width&quot;:1750,&quot;height&quot;:767,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FTUBP6QYVJP3M%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1519,&quot;dateInserted&quot;:&quot;2026-06-26T13:30:49+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FTUBP6QYVJP3M%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/TUBP6QYVJP3M/image.png" alt="image.png" height="767" width="1750" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/TUBP6QYVJP3M/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/TUBP6QYVJP3M/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/TUBP6QYVJP3M/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/TUBP6QYVJP3M/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/TUBP6QYVJP3M/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/TUBP6QYVJP3M/image.png 2000w, https://us.v-cdn.net/6038601/uploads/TUBP6QYVJP3M/image.png" sizes="100vw" /></a>
    </span>
</span>
<p>Figure 4. Increased peripheral pulmonary artery visibility with ultra-high-resolution photon-counting CT. UHR-PCD-CTPA at IQ50 (A) and IQ25 (B) vs. EID-CTPA (C). Representative measurements of the minimal distance of the last discernible pulmonary artery branch to the pleura are shown (orange line, in mm). CTPA, CT pulmonary angiography; EID, energy-integrating detector; IQ, image quality index; PCD, photon-counting detector; UHR, ultra-high resolution</p><p>Source: Pannenbecker P, Rüth C, Grunz JP, et al. Increasing pulmonary artery visibility and diagnostic confidence with ultra-high resolution photon-counting detector CT pulmonary angiography. European Radiology. 2026.</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p>Scanner</p></td><td><p>NAEOTOM Alpha.Peak</p></td></tr><tr><td><p>Software</p></td><td><p>VB10 PCCT</p><p>VB80D sybgo.via</p></td></tr><tr><td><p>Scan area</p></td><td><p>CT Pulmonary Angiography (CTPA)</p></td></tr><tr><td><p>Scan mode</p></td><td><p>Quantum HD</p></td></tr><tr><td><p>Acquisition mode</p></td><td><p>Photon-counting CT</p></td></tr><tr><td><p>Scan direction</p></td><td><p>Craniocaudal</p></td></tr><tr><td><p>Tube voltage [kV]</p></td><td><p>140</p></td></tr><tr><td><p>Effective mAs [mAs]</p></td><td><p>IQ25 or IQ50 (vendor-specific IQ level)</p></td></tr><tr><td><p>IQ level</p></td><td><p>25 or 50</p></td></tr><tr><td><p>Dose modulation</p></td><td><p>IQ-based automatic exposure control</p></td></tr><tr><td><p>CTDIvol [mGy]</p></td><td><p>IQ25: <strong>3.0 ± 1.0</strong>; IQ50: <strong>6.7 ± 2.4</strong></p></td></tr><tr><td><p>DLP [mGy·cm]</p></td><td><p>Not reported</p></td></tr><tr><td><p>Pitch</p></td><td><p>3.2 (Flash mode)</p></td></tr><tr><td><p>Matrix</p></td><td><p>n.r.</p></td></tr><tr><td><p>Slice collimation [mm]</p></td><td><p>120 × 0.2</p></td></tr><tr><td><p>Slice width [mm]</p></td><td><p>0.4</p></td></tr><tr><td><p>Reconstruction kernel</p></td><td><p>Bv48</p></td></tr><tr><td><p>Reconstruction</p></td><td><p>55 keV virtual monoenergetic images (VMI)</p></td></tr><tr><td><p>Iodine maps</p></td><td><p>Yes</p></td></tr><tr><td><p>Contrast agent</p></td><td><p>Imeron 350</p></td></tr><tr><td><p>Contrast volume</p></td><td><p>40 mL</p></td></tr><tr><td><p>Flow rate</p></td><td><p>4 mL/s</p></td></tr><tr><td><p>Bolus triggering</p></td><td><p>100 HU in pulmonary trunk; 5 s delay</p></td></tr><tr><td><p>Patient preparation</p></td><td><p>Standard pulmonary embolism protocol</p></td></tr></table></div><p></p><h3 data-id="comparison-protocol-reference-eid-ct">Comparison protocol (reference EID-CT)</h3><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p>Scanner</p></td><td><p>SOMATOM Force</p></td></tr><tr><td><p>Acquisition</p></td><td><p>Dual-energy EID-CT</p></td></tr><tr><td><p>Tube voltage</p></td><td><p>90/Sn150 kV</p></td></tr><tr><td><p>Pitch</p></td><td><p>0.55</p></td></tr><tr><td><p>Slice collimation</p></td><td><p>2 × 96 × 0.6 mm</p></td></tr><tr><td><p>Slice width</p></td><td><p>0.6 mm</p></td></tr><tr><td><p>Reconstruction kernel</p></td><td><p>Bv36</p></td></tr><tr><td><p>Contrast volume</p></td><td><p>50 mL</p></td></tr><tr><td><p>CTDIvol</p></td><td><p>4.7 ± 2.7 mGy</p></td></tr></table></div>]]>
        </description>
    </item>
    <item>
        <title>(2026) Lustermans | PCCT enables robust low-dose proton therapy planning across patient sizes</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/446/2026-lustermans-pcct-enables-robust-low-dose-proton-therapy-planning-across-patient-sizes</link>
        <pubDate>Thu, 16 Jul 2026 14:07:41 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">446@/de/discussions</guid>
        <description><![CDATA[<div><div><p>Photon-counting CT (PCCT) maintained consistent proton range estimation (R80) across different phantom sizes, tissue types, proton beam energies, and imaging doses, whereas dual-energy CT (DECT) became increasingly inaccurate in larger phantoms at reduced radiation dose.</p><p><br />
Even at low-dose imaging (CTDIvol 5 mGy), PCCT kept proton range deviations below 0.5 mm, while DECT exhibited visible photon starvation artifacts leading to proton range errors of up to 20.1 mm in the largest phantom.</p><p><br />
These findings suggest that PCCT may substantially reduce CT imaging dose in proton therapy planning without compromising treatment accuracy, making it particularly attractive for repeated imaging, adaptive radiotherapy, pediatric imaging, and large patients.</p></div></div><p></p><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fiopscience.iop.org%2Farticle%2F10.1088%2F1361-6560%2Fae50c8" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/B6Y1UPA9RSPY\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:772941,&quot;width&quot;:1725,&quot;height&quot;:1002,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FB6Y1UPA9RSPY%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1540,&quot;dateInserted&quot;:&quot;2026-07-16T14:04:52+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FB6Y1UPA9RSPY%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/B6Y1UPA9RSPY/image.png" alt="image.png" height="1002" width="1725" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/B6Y1UPA9RSPY/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/B6Y1UPA9RSPY/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/B6Y1UPA9RSPY/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/B6Y1UPA9RSPY/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/B6Y1UPA9RSPY/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/B6Y1UPA9RSPY/image.png 2000w, https://us.v-cdn.net/6038601/uploads/B6Y1UPA9RSPY/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1. </strong>Visualization of the workflow followed in this study, including CT scanning, VMI generation, SPR estimation using the Hünemohr method (Hünemohr et al 2014), and a proton plan was created on the phantom. Additionally, the three assessments, phantom size-, traversed tissue type-, and proton energy-dependency are shown with the quantification of proton range, defined as the range at the 80% distal fall-off (R80) per proton spot, to assess range differences. Abbreviations: SPR—stopping-power ratio, DECT—dual-energy computed tomography, PCCT—photon-counting CT.</p><p><strong>Source:</strong><br />
Lustermans D, Fonseca GP, Vilches-Freixas G, et al. Evaluation of proton range differences in photon-counting and dual-energy computed tomography across imaging doses and anthropomorphic phantom sizes. Physics in Medicine &amp; Biology. 2026;71:065008.</p><p></p><p></p><h2 data-id="protocol">Protocol</h2><p></p><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p><strong>Scanner (PCCT)</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scanner (DECT)</strong></p></td><td><p>SOMATOM Confidence</p></td></tr><tr><td><p><strong>Application</strong></p></td><td><p>Proton therapy planning</p></td></tr><tr><td><p><strong>Phantoms</strong></p></td><td><p>Anthropomorphic head phantom + 3D-printed abdomen phantoms (XS, M, L, XL)</p></td></tr><tr><td><p><strong>Tube voltage (PCCT)</strong></p></td><td><p>120 kVp</p></td></tr><tr><td><p><strong>Tube voltage (DECT)</strong></p></td><td><p>80 / 140 kVp</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>5, 10, 20</p></td></tr><tr><td><p><strong>Detector collimation (PCCT)</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Detector collimation (DECT)</strong></p></td><td><p>32 × 0.6 mm</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>0.35</p></td></tr><tr><td><p><strong>Slice thickness</strong></p></td><td><p>1.0 mm</p></td></tr><tr><td><p><strong>Reconstruction kernel</strong></p></td><td><p>Qr40</p></td></tr><tr><td><p><strong>Iterative reconstruction (PCCT)</strong></p></td><td><p>QIR strength 3</p></td></tr><tr><td><p><strong>Iterative reconstruction (DECT)</strong></p></td><td><p>SAFIRE strength 3</p></td></tr><tr><td><p><strong>Virtual monoenergetic images</strong></p></td><td><p>70 keV and 180 keV</p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p>768 × 768 (abdomen PCCT); 512 × 512 (head PCCT &amp; DECT)</p></td></tr><tr><td><p><strong>Field of view</strong></p></td><td><p>500 mm (abdomen), 300 mm (head)</p></td></tr><tr><td><p><strong>SPR estimation</strong></p></td><td><p>Hünemohr method</p></td></tr><tr><td><p><strong>Treatment planning</strong></p></td><td><p>RayStation 2024B, Monte Carlo dose calculation</p></td></tr><tr><td><p><strong>Primary endpoint</strong></p></td><td><p>Proton range (R80)</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Parameter</p></th><th><p>Main finding</p></th></tr><tr><td><p>Low-dose imaging</p></td><td><p>PCCT maintained stable proton range estimation even at <strong>5 mGy</strong></p></td></tr><tr><td><p>Proton range deviation</p></td><td><p>PCCT &lt;0.5 mm across all phantom sizes and tissue types</p></td></tr><tr><td><p>DECT low-dose performance</p></td><td><p>Range errors increased with phantom size, reaching <strong>20.1 mm</strong> in the XL phantom</p></td></tr><tr><td><p>Image artifacts</p></td><td><p>Photon starvation substantially degraded DECT low-dose performance in large phantoms; PCCT avoided these artifacts</p></td></tr><tr><td><p>Tissue dependency</p></td><td><p>PCCT remained stable across beams traversing soft tissue, bowel and bone; DECT errors increased through denser tissues</p></td></tr><tr><td><p>Clinical implication</p></td><td><p>PCCT enables substantial CT dose reduction for proton therapy planning while preserving range accuracy, potentially benefiting adaptive radiotherapy, pediatric imaging, repeated follow-up imaging and obese patients.</p></td></tr></table></div>]]>
        </description>
    </item>
    <item>
        <title>(2026) Lamaj | PCCT enables accurate head-and-neck radiotherapy planning using RED and VMI recons</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/432/2026-lamaj-pcct-enables-accurate-head-and-neck-radiotherapy-planning-using-red-and-vmi-recons</link>
        <pubDate>Fri, 26 Jun 2026 13:14:49 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">432@/de/discussions</guid>
        <description><![CDATA[<div><div><p>Photon-counting CT enabled clinically acceptable radiotherapy treatment planning for all head-and-neck cancer patients, with dose-volume metrics differing by &lt;5% compared with conventional EID-CT plans.</p><p><br />
Relative electron density (RED) images required no scanner-specific calibration, while 70 keV virtual monoenergetic images (VMI70) also provided accurate dose calculations after standard HU-to-RED calibration.</p><p><br />
PCCT-derived RED maps demonstrated improved robustness against dental metal artifacts, supporting their use as a quantitative foundation for </p><p>radiotherapy planning workflows.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS2405631626000953" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/B9451DPOQ3DF\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:115877,&quot;width&quot;:355,&quot;height&quot;:200,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FB9451DPOQ3DF%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1515,&quot;dateInserted&quot;:&quot;2026-06-26T13:12:00+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FB9451DPOQ3DF%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/B9451DPOQ3DF/image.png" alt="image.png" height="200" width="355" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/B9451DPOQ3DF/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/B9451DPOQ3DF/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/B9451DPOQ3DF/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/B9451DPOQ3DF/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/B9451DPOQ3DF/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/B9451DPOQ3DF/image.png 2000w, https://us.v-cdn.net/6038601/uploads/B9451DPOQ3DF/image.png" sizes="100vw" /></a>
    </span>
</span>
<p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/T8YKS6F59ERO\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:114049,&quot;width&quot;:623,&quot;height&quot;:203,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FT8YKS6F59ERO%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1516,&quot;dateInserted&quot;:&quot;2026-06-26T13:13:13+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FT8YKS6F59ERO%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/T8YKS6F59ERO/image.png" alt="image.png" height="203" width="623" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/T8YKS6F59ERO/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/T8YKS6F59ERO/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/T8YKS6F59ERO/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/T8YKS6F59ERO/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/T8YKS6F59ERO/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/T8YKS6F59ERO/image.png 2000w, https://us.v-cdn.net/6038601/uploads/T8YKS6F59ERO/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Fig. 1. </strong>Patient 9 PCD-CT reconstructions. A) Virtual monoenergetic image of 70 keV (VMI70) without iterative metal artifact reduction (iMAR); B) VMI70 with iMAR; C) Relative electron density (RED) image with iMAR. All images shown in the abdomen window (CT values between −125 and 225 HU). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p><p><em>Source: Lamaj E, Wohlfahrt P, Wilke L, et al. Photon-counting detector computed tomography in treatment planning of head-and-neck cancer. Physics and Imaging in Radiation Oncology. 2026;39:100995.</em></p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p>Scanner</p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p>Software</p></td><td><p>VB20 prototype (RED reconstruction)</p></td></tr><tr><td><p>Scan area</p></td><td><p>Head and neck</p></td></tr><tr><td><p>Scan mode</p></td><td><p>Single-source spiral</p></td></tr><tr><td><p>Tube voltage [kV]</p></td><td><p>120</p></td></tr><tr><td><p>Reconstruction kernel</p></td><td><p>Qr40 (dose calculation)</p></td></tr><tr><td><p>Iterative reconstruction</p></td><td><p>iMAR (Dental Fillings preset)</p></td></tr><tr><td><p>Reconstruction type</p></td><td><p>Relative Electron Density (RED) map and Virtual Monoenergetic Images (70 keV)</p></td></tr><tr><td><p>Spectral reconstruction</p></td><td><p>RED images (vendor prototype) + 70 keV VMI</p></td></tr><tr><td><p>Contrast agent</p></td><td><p>None</p></td></tr><tr><td><p>Patient preparation</p></td><td><p>Standard radiotherapy simulation</p></td></tr><tr><td><p>Treatment planning</p></td><td><p>Varian Eclipse (Acuros XB), 6 MV VMAT</p></td></tr></table></div><p></p><p>Lamaj E, Wohlfahrt P, Wilke L, et al. <em>Photon-counting detector computed tomography in treatment planning of head-and-neck cancer.</em> Physics and Imaging in Radiation Oncology. 2026;39:100995.</p>]]>
        </description>
    </item>
    <item>
        <title>(2025) Neubauer | Breast cancer response assessment under NAST using thoracic PCCT</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/359/2025-neubauer-breast-cancer-response-assessment-under-nast-using-thoracic-pcct</link>
        <pubDate>Fri, 24 Apr 2026 13:24:46 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">359@/de/discussions</guid>
        <description><![CDATA[<div><div><p>The authors showed that prone thoracic contrast-enhanced PCCT detected reduced tumor burden after neoadjuvant systemic therapy in all 9 patients.</p><p></p><p></p><p>Best-practice implication: when thoracic PCCT is clinically indicated anyway, prone positioning can allow opportunistic local breast tumor and axillary assessment without extra scan time, radiation, or contrast.</p><p></p><p></p><p>The study supports using spectral reconstructions, especially monoenergetic images and iodine maps, for tumor-size and enhancement assessment, but larger studies are needed before replacing dedicated breast MRI.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1186%2Fs41747-025-00576-z" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/MKWBRFZXFWH1\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:377577,&quot;width&quot;:733,&quot;height&quot;:608,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FMKWBRFZXFWH1%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1323,&quot;dateInserted&quot;:&quot;2026-04-24T13:19:49+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FMKWBRFZXFWH1%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/MKWBRFZXFWH1/image.png" alt="image.png" height="608" width="733" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/MKWBRFZXFWH1/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/MKWBRFZXFWH1/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/MKWBRFZXFWH1/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/MKWBRFZXFWH1/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/MKWBRFZXFWH1/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/MKWBRFZXFWH1/image.png 2000w, https://us.v-cdn.net/6038601/uploads/MKWBRFZXFWH1/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 4.</strong> Patient with right-sided breast tumor (arrow) of no special type, G2, ER+/PR+/HER2-, visualized in breast MRI at initial diagnosis with T1w-subtraction after contrast administration (a) and fat-saturated T2w sequence (b). Photon-counting detector computed tomography with monoenergetic reconstruction (c, e) and iodine map (d, f) shows the tumor at initial tumor staging before NAST (c, d) and with a marked decline of tumor size after NAST (e, f). ER, Estrogen receptor; HER2, Human epidermal growth factor receptor; MRI, Magnetic resonance imaging; NAST, Neoadjuvant systemic therapy; PR, Progesterone receptor</p><p><em>Source</em><em><strong>:</strong></em><em> Source: Neubauer et al., European Radiology Experimental, 2025.</em></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Setting</p></th></tr><tr><td><p>Scanner</p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p>Scan area</p></td><td><p>Thorax / breasts / axillary regions</p></td></tr><tr><td><p>Scan mode</p></td><td><p>Dual-source thoracic PCCT, prone position</p></td></tr><tr><td><p>Tube voltage [kV]</p></td><td><p>120</p></td></tr><tr><td><p>Effective mAs [mAs]</p></td><td><p>Quality reference 142 mAs</p></td></tr><tr><td><p>Matrix</p></td><td><p>1024 × 1024</p></td></tr><tr><td><p>Slice width [mm]</p></td><td><p>2</p></td></tr><tr><td><p>Reconstruction increment [mm]</p></td><td><p>2</p></td></tr><tr><td><p>Reconstruction kernel</p></td><td><p>Br40</p></td></tr><tr><td><p>Iterative reconstruction</p></td><td><p>QIR</p></td></tr><tr><td><p>Spectral reconstruction</p></td><td><p>iodine map, virtual unenhanced</p></td></tr><tr><td><p>keV level [keV]</p></td><td><p>65</p></td></tr><tr><td><p>Contrast agent</p></td><td><p>Iopromide 370 mgI/mL</p></td></tr><tr><td><p>Contrast volume</p></td><td><p>80 mL + 0.5 mL/kg body weight, max. 140 mL</p></td></tr><tr><td><p>Flow rate</p></td><td><p>3 mL/s saline chaser; contrast flow n.a.</p></td></tr><tr><td><p>Saline chaser</p></td><td><p>Yes</p></td></tr><tr><td><p>Acquisition phase</p></td><td><p>Fixed 85 s delay</p></td></tr></table></div><p></p><p>Neubauer C, Nattenmüller J, Bamberg F, Windfuhr-Blum M, Neubauer J. <em>Breast cancer assessment under neoadjuvant systemic therapy using thoracic photon-counting detector computed tomography in prone position: a pilot study.</em> Eur Radiol Exp. 2025;9:41. doi: 10.1186/s41747-025-00576-z.</p>]]>
        </description>
    </item>
    <item>
        <title>Iodine Mapping PCCT for Early Small Bowel Ischemia due to a Rare Uterine Band</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/352/iodine-mapping-pcct-for-early-small-bowel-ischemia-due-to-a-rare-uterine-band</link>
        <pubDate>Mon, 13 Apr 2026 07:21:30 +0000</pubDate>
        <category>Case reports</category>
        <dc:creator>Kunhimohamed Poolakkal</dc:creator>
        <guid isPermaLink="false">352@/de/discussions</guid>
        <description><![CDATA[<h3 data-id="dr-mustafa-al-gazzawi-senior-specialist-diagnostic-radiology-dr-thair-s-abdulla-head-of-radiology-consultant-radiologist"><strong>Dr. Mustafa Al-Gazzawi</strong>, Senior Specialist (Diagnostic Radiology)<strong><br />
Dr. Thair S. Abdulla</strong><br />&#13;, Head of Radiology, Consultant Radiologist</h3><h4 data-id="courtesy-of-al-ahli-hospital-doha-qatar-college-of-medicine-qu-health-qatar-university-doha-qatar-april-13-2026"><strong>Courtesy of Al‑Ahli Hospital, Doha, Qatar. College of Medicine, QU Health, Qatar University, Doha, Qatar</strong><br /><br />
April 13, 2026</h4><div data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/KPQXZN472U7W\/mea-iodine-mapping-pcct-for-early-small-bowel-ischemia-due-to-a-rare-uterine-band.pdf&quot;,&quot;name&quot;:&quot;MEA_Iodine Mapping PCCT for Early Small Bowel Ischemia due to a Rare Uterine Band.pdf&quot;,&quot;type&quot;:&quot;application\/pdf&quot;,&quot;size&quot;:1422060,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FKPQXZN472U7W%2Fmea-iodine-mapping-pcct-for-early-small-bowel-ischemia-due-to-a-rare-uterine-band.pdf&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1590,&quot;dateInserted&quot;:&quot;2026-07-30T09:14:03+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;file&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <a rel="nofollow" href="https://connect.siemens-healthineers.com/api/v2/media/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FKPQXZN472U7W%2Fmea-iodine-mapping-pcct-for-early-small-bowel-ischemia-due-to-a-rare-uterine-band.pdf" download="" aria-label="MEA_Iodine Mapping PCCT for Early Small Bowel Ischemia due to a Rare Uterine Band.pdf">
        MEA_Iodine Mapping PCCT for Early Small Bowel Ischemia due to a Rare Uterine Band.pdf
    </a>
</div>
<p><strong>Abstract</strong><br />
Small bowel ischemia remains difficult to diagnose early, especially when caused by extrinsic mechanical compression rather than vascular occlusion. Photon counting Computed Tomography (PCCT) allows iodine-based perfusion assessment with significantly improved spectral resolution.</p><p><strong>Case presentation:</strong><br />
A 55-year-old woman with multiple comorbidities presented with acute severe lower abdominal pain and vomiting. Conventional imaging revealed a closed-loop small bowel obstruction without definitive evidence of ischemia. PCCT iodine mapping demonstrated a sharply demarcated segment of absent iodine enhancement in a distal ileal loop, indicating loss of perfusion in that segment. Urgent exploratory laparotomy identified a dense fibrous uterine band causing complete obstruction and an ischemic 40 cm ileal loop, which required resection with primary anastomosis.</p><p><strong>Conclusion:</strong><br />
PCCT iodine mapping enabled early identification of bowel ischemia when standard CT was nondiagnostic. This case highlights PCCT’s growing value in emergency abdominal imaging.</p><p><strong>Keywords:</strong> Fibrotic bad, Bowel Ischemia, Iodine Mapping, Photon Counting CT</p><p><strong></strong></p><h2 data-id="introduction"><strong>Introduction</strong></h2><p>Small bowel ischemia is a life-threatening condition with reported mortality rates exceeding 50% when diagnosis is delayed. Early symptoms are nonspecific, and laboratory values such as leukocytosis, lactate, and CRP may remain normal until late stages, limiting clinical detection. [1] Conventional CT is the first line modality, yet its early-stage diagnostic sensitivity remains limited, sometimes as low as 64%, particularly before mucosal necrosis or pneumatosis develop. [1] </p><p>Dual energy CT (DECT) introduced iodine-based perfusion mapping, improving sensitivity in early ischemia. [2] However, DECT detectors are still energy integrating and subject to noise and reduced spectral precision. </p><p>Photon counting CT (PCCT) represents a major technological advancement. PCCT directly counts individual X-Ray photons and sorts them by energy, enabling higher spatial resolution, reduced electronic noise, and more accurate iodine quantification. [3] This makes PCCT particularly useful for detecting subtle perfusion changes, including early ischemia.</p><p>Fibrotic uterine origin bands represent an exceptionally rare etiology of small bowel obstruction and ischemia. Pelvic adhesions occur in more than 50% of women following Caesarean delivery. [5] Yet reports of uterine fibrotic bands producing closed loop ischemia are extremely scarce. </p><p>This case demonstrates how PCCT iodine maps identified critical ischemia despite standard images appearing inconclusive.</p><h3 data-id="clinical-case-study-1"><strong>Clinical Case Study 1</strong></h3><p>A 55-year-old woman presented to the Emergency Department with acute, severe abdominal pain that had begun earlier that morning. The pain was continuous and predominantly localized in the lower abdomen, without radiation. She reported two episodes of vomiting and one bowel movement on the day of presentation, with no associated diarrhea. There was no history of fever, dysuria, hematuria, or other urinary symptoms. She described experiencing a similar but self-limiting episode of abdominal pain approximately two months earlier, which had resolved without medical intervention.</p><p>The patient had multiple chronic comorbidities, including type 2 diabetes mellitus, ischemic heart disease status post percutaneous coronary intervention, hypertension, dyslipidemia, depression, and overweight. She was a lifelong non-smoker. Her regular medications included insulin, ezetimibe/atorvastatin, acetylsalicylic acid, bisoprolol, and evolocumab. She had a surgical history of a cesarean section and a laparoscopic sleeve gastrectomy.</p><p>On clinical examination, the patient was alert but in moderate distress due to pain. She was hemodynamically stable, with no signs of shock. Abdominal examination revealed generalized guarding and central abdominal tenderness, with a firm lower abdomen more pronounced on the right side. Laboratory investigations showed potassium of 3.2 mmol/L, creatinine of 51 µmol/L, urea of 2.7 mmol/L, white blood cell count of 12.9 × 10⁹/L, hemoglobin of 13.4 g/dL, C-reactive protein of 1.5 mg/L, and random blood glucose of 159 mg/dL.</p><p>Initial non-contrast CT of the abdomen demonstrated mildly distended, fluid-filled distal ileal loops in the pelvis, measuring up to 2.2 cm, with mild mucosal thickening and associated mesenteric congestion. These findings raised concern for early vascular compromise or a developing small bowel obstruction. A small volume of pelvic free fluid was also noted (Fig. 1).</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/7QTNX829FPL7\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:85365,&quot;width&quot;:256,&quot;height&quot;:266,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F7QTNX829FPL7%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1501,&quot;dateInserted&quot;:&quot;2026-06-26T09:55:41+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F7QTNX829FPL7%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/7QTNX829FPL7/image.png" alt="image.png" height="266" width="256" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/7QTNX829FPL7/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/7QTNX829FPL7/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/7QTNX829FPL7/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/7QTNX829FPL7/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/7QTNX829FPL7/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/7QTNX829FPL7/image.png 2000w, https://us.v-cdn.net/6038601/uploads/7QTNX829FPL7/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><em>Fig.1: Coronal CT scan (without contrast) showed a fibrotic band extending from the fundus of uterus upward to the site of transitional zone (blue arrow), with focal segment of distal small bowel with early ischemic changes (yellow arrow).</em></p><p></p><p>Contrast-enhanced CT abdomen and pelvis with oral and intra-venous contrast revealed increased free intraperitoneal fluid. Oral contrast limited to the proximal small bowel, which appeared normal. A distal small bowel loop in the left lower abdomen showing significant wall edema and poor enhancement on arterial and venous phases. Marked mesenteric congestion around the affected loop. Fibrotic band extending from the fundus of uterus, up to the site of transitional zone. No pneumatosis or portal venous gas were noted. Patent superior mesenteric artery and superior mesenteric vein. Indeterminate transition point.</p><p>These findings were equivocal for bowel ischemia. The impression was closed-loop small bowel obstruction with suspected vascular compromise, likely secondary to adhesions, with progressive features concerning for bowel ischemia. Fig. (2)</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/YN0RFWK7ABAY\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:258606,&quot;width&quot;:584,&quot;height&quot;:534,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FYN0RFWK7ABAY%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1504,&quot;dateInserted&quot;:&quot;2026-06-26T09:58:09+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FYN0RFWK7ABAY%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/YN0RFWK7ABAY/image.png" alt="image.png" height="534" width="584" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/YN0RFWK7ABAY/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/YN0RFWK7ABAY/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/YN0RFWK7ABAY/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/YN0RFWK7ABAY/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/YN0RFWK7ABAY/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/YN0RFWK7ABAY/image.png 2000w, https://us.v-cdn.net/6038601/uploads/YN0RFWK7ABAY/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><em>Fig 2: Coronal CT scan (oral and IV contrast) showed a fibrotic band (yellow arrow) extending from the fundus<br />&#13; of uterus (blue arrow) upward to the site of transitional zone.</em></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/TG182P5ON298\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:227384,&quot;width&quot;:582,&quot;height&quot;:533,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FTG182P5ON298%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1505,&quot;dateInserted&quot;:&quot;2026-06-26T09:58:26+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FTG182P5ON298%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/TG182P5ON298/image.png" alt="image.png" height="533" width="582" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/TG182P5ON298/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/TG182P5ON298/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/TG182P5ON298/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/TG182P5ON298/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/TG182P5ON298/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/TG182P5ON298/image.png 2000w, https://us.v-cdn.net/6038601/uploads/TG182P5ON298/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><em>Fig 2: Sagittal CT scan (oral and IV contrast) showed a fibrotic band extending from the fundus of uterus<br />&#13; upward to the site of transitional zone.</em></p><p><strong>PCCT Iodine Mapping</strong> revealed a 30–50 cm segment of distal ileum with complete absence of iodine enhancement, with a sharply defined cutoff compared to adjacent normally enhanced loops. This pattern strongly suggested severe perfusion failure despite nondiagnostic conventional CT findings.</p><p></p><div><table><colgroup><col /><col /><col /></colgroup><tr><th><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/S68LU239OA15\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:135852,&quot;width&quot;:452,&quot;height&quot;:416,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FS68LU239OA15%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1507,&quot;dateInserted&quot;:&quot;2026-06-26T09:59:21+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FS68LU239OA15%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/S68LU239OA15/image.png" alt="image.png" height="416" width="452" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/S68LU239OA15/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/S68LU239OA15/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/S68LU239OA15/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/S68LU239OA15/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/S68LU239OA15/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/S68LU239OA15/image.png 2000w, https://us.v-cdn.net/6038601/uploads/S68LU239OA15/image.png" sizes="100vw" /></a>
    </span>
</span>
</th><th><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/IPIJFYRAQ3Q3\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:109999,&quot;width&quot;:443,&quot;height&quot;:402,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FIPIJFYRAQ3Q3%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1508,&quot;dateInserted&quot;:&quot;2026-06-26T09:59:37+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FIPIJFYRAQ3Q3%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/IPIJFYRAQ3Q3/image.png" alt="image.png" height="402" width="443" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/IPIJFYRAQ3Q3/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/IPIJFYRAQ3Q3/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/IPIJFYRAQ3Q3/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/IPIJFYRAQ3Q3/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/IPIJFYRAQ3Q3/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/IPIJFYRAQ3Q3/image.png 2000w, https://us.v-cdn.net/6038601/uploads/IPIJFYRAQ3Q3/image.png" sizes="100vw" /></a>
    </span>
</span>
</th></tr></table></div><p>Fig. 4: Axial PCCT scan (left) (oral and IV contrast) iodine mapping showed a normal mucosal iodine uptake<br />&#13; (yellow arrow). Axial conventional CT scan (right) (oral and IV contrast) showed faint normal mucosal contrast uptake<br />&#13; (yellow arrow).</p><p></p><div><table><colgroup><col /><col /><col /></colgroup><tr><th><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/741NXPFN9G4Y\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:165084,&quot;width&quot;:447,&quot;height&quot;:343,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F741NXPFN9G4Y%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1509,&quot;dateInserted&quot;:&quot;2026-06-26T10:01:26+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F741NXPFN9G4Y%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/741NXPFN9G4Y/image.png" alt="image.png" height="343" width="447" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/741NXPFN9G4Y/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/741NXPFN9G4Y/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/741NXPFN9G4Y/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/741NXPFN9G4Y/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/741NXPFN9G4Y/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/741NXPFN9G4Y/image.png 2000w, https://us.v-cdn.net/6038601/uploads/741NXPFN9G4Y/image.png" sizes="100vw" /></a>
    </span>
</span>
</th><th><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/JDJUGLI0SCL4\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:93729,&quot;width&quot;:357,&quot;height&quot;:294,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJDJUGLI0SCL4%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1510,&quot;dateInserted&quot;:&quot;2026-06-26T10:01:34+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJDJUGLI0SCL4%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/JDJUGLI0SCL4/image.png" alt="image.png" height="294" width="357" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/JDJUGLI0SCL4/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/JDJUGLI0SCL4/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/JDJUGLI0SCL4/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/JDJUGLI0SCL4/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/JDJUGLI0SCL4/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/JDJUGLI0SCL4/image.png 2000w, https://us.v-cdn.net/6038601/uploads/JDJUGLI0SCL4/image.png" sizes="100vw" /></a>
    </span>
</span>
</th></tr><tr><td><p>Fig. 5a: Comparative axial images between iodine mapping image and conventional CT scan image.</p></td><td><p>Fig 5b: Yellow arrow showed focal segment of small bowel devoted from iodine /contrast uptake, blue arrow<br />&#13; showed normal mucosal enhancement.</p></td></tr><tr><td><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/3D3VDPDCI31X\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:57561,&quot;width&quot;:484,&quot;height&quot;:322,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F3D3VDPDCI31X%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1511,&quot;dateInserted&quot;:&quot;2026-06-26T10:02:31+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F3D3VDPDCI31X%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/3D3VDPDCI31X/image.png" alt="image.png" height="322" width="484" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/3D3VDPDCI31X/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/3D3VDPDCI31X/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/3D3VDPDCI31X/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/3D3VDPDCI31X/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/3D3VDPDCI31X/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/3D3VDPDCI31X/image.png 2000w, https://us.v-cdn.net/6038601/uploads/3D3VDPDCI31X/image.png" sizes="100vw" /></a>
    </span>
</span>
</td><td><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/K1SCTA6HMRMY\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:135732,&quot;width&quot;:484,&quot;height&quot;:301,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FK1SCTA6HMRMY%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1512,&quot;dateInserted&quot;:&quot;2026-06-26T10:02:37+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FK1SCTA6HMRMY%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/K1SCTA6HMRMY/image.png" alt="image.png" height="301" width="484" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/K1SCTA6HMRMY/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/K1SCTA6HMRMY/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/K1SCTA6HMRMY/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/K1SCTA6HMRMY/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/K1SCTA6HMRMY/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/K1SCTA6HMRMY/image.png 2000w, https://us.v-cdn.net/6038601/uploads/K1SCTA6HMRMY/image.png" sizes="100vw" /></a>
    </span>
</span>
</td></tr><tr><td><p>Fig.6a: Comparative coronal images between iodine mapping image and conventional CT scan<br />&#13; image</p></td><td><p>Fig. 6b: Blue arrow showed focal segment of small bowel devoted from iodine /contrast uptake, yellow arrow<br />&#13; showed normal mucosal enhancement.</p></td></tr><tr><td><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/HWS48JQUJPA3\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:166023,&quot;width&quot;:471,&quot;height&quot;:369,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FHWS48JQUJPA3%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1513,&quot;dateInserted&quot;:&quot;2026-06-26T10:03:51+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FHWS48JQUJPA3%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/HWS48JQUJPA3/image.png" alt="image.png" height="369" width="471" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/HWS48JQUJPA3/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/HWS48JQUJPA3/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/HWS48JQUJPA3/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/HWS48JQUJPA3/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/HWS48JQUJPA3/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/HWS48JQUJPA3/image.png 2000w, https://us.v-cdn.net/6038601/uploads/HWS48JQUJPA3/image.png" sizes="100vw" /></a>
    </span>
</span>
</td><td><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/KCASHQ15YHPG\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:141546,&quot;width&quot;:473,&quot;height&quot;:375,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FKCASHQ15YHPG%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1514,&quot;dateInserted&quot;:&quot;2026-06-26T10:04:04+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FKCASHQ15YHPG%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/KCASHQ15YHPG/image.png" alt="image.png" height="375" width="473" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/KCASHQ15YHPG/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/KCASHQ15YHPG/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/KCASHQ15YHPG/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/KCASHQ15YHPG/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/KCASHQ15YHPG/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/KCASHQ15YHPG/image.png 2000w, https://us.v-cdn.net/6038601/uploads/KCASHQ15YHPG/image.png" sizes="100vw" /></a>
    </span>
</span>
</td></tr><tr><td><p>Fig. 7a: Comparative sagittal images between iodine mapping image and conventional CT scan image</p></td><td><p>Fig. 7b: Yellow arrow showed focal segment of small bowel devoted from iodine /contrast uptake, blue arrow<br />&#13; showed normal mucosal enhancement.</p></td></tr></table></div><p></p><p>The patient underwent an urgent exploratory laparotomy, which revealed a large volume of serous peritoneal fluid and an ischemic loop of small bowel centrally located within the peritoneal cavity.</p><p>A dense fibrous band extending from the right posterior uterine wall to the posterior abdominal wall near the right iliac fossa was identified, causing complete small bowel obstruction.</p><p>The fibrous band was divided and excised. The compromised small bowel segment measured approximately 40 cm and was located about 1 meter proximal to the ileocecal junction. Despite repeated application of warm saline and observation for 25 minutes, there was no meaningful improvement in perfusion.</p><p>A resection of the non-viable segment was therefore performed, followed by side-to-side anastomosis using a linear stapler. The staple line was reinforced with a second layer of sutures. A pelvic drain was placed. The procedure was completed without intraoperative complications.</p><p>The patient showed gradual improvement postoperatively. Her nasogastric tube and Foley catheter were removed on postoperative day 1. She passed flatus on postoperative day 2 and had her first bowel movement on day 3.</p><p>During recovery, she developed a chest infection, which was evaluated and treated by pulmonology, then she was discharged on postoperative day 6 in stable condition.</p><p>Gross examination of the band revealed an irregular, firm tissue fragment measuring 1.5 x 1 x 0.5 cm. Microscopical examination revealed a vascularized fibrous tissue band.</p><p><strong></strong></p><h2 data-id="discussion"><strong>Discussion</strong></h2><p>Small bowel ischemia continues to be one of the most challenging abdominal emergencies to diagnose early. Clinical presentation is often nonspecific, and laboratory markers remain limited in sensitivity. Conventional CT, although essential, frequently lacks sensitivity in early stages.</p><p>PCCT provides significant advantages due to its ability to detect subtle enhancement differences and quantify iodine concentration with high precision. Compared to DECT, PCCT offers superior energy resolution, reduced noise, and improved contrast to noise ratios, contributing to better visualization of bowel wall perfusion abnormalities.</p><p>PCCT images appeared inconclusive, iodine maps revealed a complete lack of enhancement in a diseased segment, providing diagnostic clarity. This timely detection enabled urgent surgical intervention, preventing perforation and further complications.</p><p>Fibrotic bands arising from the uterus are exceptionally uncommon. Although pelvic adhesions after Caesarean delivery are common, fibrotic uterine bands producing strangulating obstruction are sparsely documented.</p><p><strong></strong></p><h2 data-id="conclusion"><strong>Conclusion</strong></h2><p>PCCT iodine mapping enabled early recognition of small bowel ischemia secondary to a rare uterine fibrotic band. When conventional CT is equivocal, PCCT offers critical diagnostic insight by precisely evaluating bowel perfusion.</p><p></p><p><strong>References</strong></p><ol><li>Menke J. Diagnostic accuracy of multidetector CT in acute mesenteric ischemia. Radiology. 2010;256(1):93–101.</li><li>Giraud R, Hetzel J, Bader H, et al. Assessment of small bowel ischemia using dual-energy CT iodine concentration. Diagn Interv Imaging. 2025;106(4):126–134.</li><li>Schwarz F et al. Photon-counting CT: abdominal applications. Br J Radiol. 2024.</li><li>Shaheen NH et al. Photon-counting CT for diagnosis of bowel infarction. Radiol Case Rep. 2022;17(5):1674–1677.</li><li>Attard JA, MacLean AR. Adhesive small bowel obstruction. Can J Surg. 2007;50(4):291–300.</li></ol>]]>
        </description>
    </item>
    <item>
        <title>(2024) Tóth | Iodine quantification differentiates renal cysts vs tumors on PCCT</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/345/2024-toth-iodine-quantification-differentiates-renal-cysts-vs-tumors-on-pcct</link>
        <pubDate>Fri, 10 Apr 2026 11:54:14 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">345@/de/discussions</guid>
        <description><![CDATA[<div><div><p>Automated iodine maps on PCCT showed strong diagnostic performance to differentiate renal cysts from neoplasms, with AUC up to 0.99.</p><p></p><p>Renal cysts consistently demonstrated near-zero iodine concentration, while neoplasms showed higher and more heterogeneous iodine values.</p><p></p><p>Minimum iodine concentration in suspicious regions was particularly powerful, nearly perfectly separating benign vs malignant lesions.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11021115%2F" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/GGG4TCAVUNOQ\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:305163,&quot;width&quot;:756,&quot;height&quot;:359,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FGGG4TCAVUNOQ%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1277,&quot;dateInserted&quot;:&quot;2026-04-10T11:51:30+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FGGG4TCAVUNOQ%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/GGG4TCAVUNOQ/image.png" alt="image.png" height="359" width="756" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/GGG4TCAVUNOQ/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/GGG4TCAVUNOQ/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/GGG4TCAVUNOQ/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/GGG4TCAVUNOQ/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/GGG4TCAVUNOQ/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/GGG4TCAVUNOQ/image.png 2000w, https://us.v-cdn.net/6038601/uploads/GGG4TCAVUNOQ/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 2.</strong> (a) A 86-year-old female who presented with abdominal pain. Reconstructed iodine quantification map of the axial CT image shows the left kidney with renal cyst. For homogeneous lesions, one ROI was placed in the interior of the renal lesion, as large as possible to cover the entire lesion (yellow arrow pointing to the ROI shown as yellow circle). (b) A 64-year-old female presented for RCC staging. A reconstructed iodine quantification map of the axial CT image shows the right kidney with renal neoplasm. For heterogeneous lesions, after the placement of the first ROI (yellow arrow pointing to the ROI shown as yellow circle), a secondary ROI (yellow star marking the ROI shown as yellow circle) was placed on the area of the highest conspicuity of iodine concentration. (CT: Computed tomography, RCC: Renal cell carcinoma, ROI: Region of interest).</p><p>Source: Tóth et al., <em>Journal of Clinical Imaging Science</em>, 2024</p><p></p><h3 data-id="protocol">Protocol</h3><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Abdomen</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>QuantumPlus </p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>Effective mAs [mAs]</strong></p></td><td><p>184.9 ± 77.3</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>249</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>CARE Dose4D</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>15.2 ± 6.6</p></td></tr><tr><td><p><strong>DLP [mGy*cm]</strong></p></td><td><p>1020.5 ± 608.0</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.5</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>0.8</p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p>512 × 512</p></td></tr><tr><td><p><strong>Slice collimation [mm]</strong></p></td><td><p>144 × 3</p></td></tr><tr><td><p><strong>Slice width [mm]</strong></p></td><td><p>3 </p></td></tr><tr><td><p><strong>keV level [keV]</strong></p></td><td><p>n.a.</p></td></tr><tr><td><p><strong>Contrast agent</strong></p></td><td><p>Omnipaque 350 mgI/mL</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>1.25 ± 0.13 mL/kg</p></td></tr><tr><td><p><strong>Flow rate</strong></p></td><td><p>2.96 ± 0.59 mL/s</p></td></tr></table></div><p>Tóth A, Chamberlin JH, Mendez S, Varga-Szemes A, Hardie AD. <strong>Iodine quantification of renal lesions: Preliminary results using spectral-based material extraction on photon-counting CT.</strong> <em>J Clin Imaging Sci.</em> 2024;14:7. doi:10.25259/JCIS_1_2024</p>]]>
        </description>
    </item>
    <item>
        <title>(2024) Hoeijmakers | PCCT enables contrast media reduction in abdominal imaging</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/344/2024-hoeijmakers-pcct-enables-contrast-media-reduction-in-abdominal-imaging</link>
        <pubDate>Fri, 10 Apr 2026 11:48:02 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">344@/de/discussions</guid>
        <description><![CDATA[<div><div><p>PCCT reduced total iodine load by 20.1% for abdominal portal venous phase CT compared with an individualized kV-adapted EID-CT protocol, while maintaining diagnostic image quality.</p><p></p><p>Despite lower liver attenuation at the standard 60 keV reconstruction, PCCT achieved significantly higher SNR and CNR than EID-CT.</p><p></p><p>All scans on both systems were rated as diagnostically sufficient by both readers.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0720048X24003966" rel="nofollow noopener ugc" role="button">Access the publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/MOMQUVQLKAZM\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:251844,&quot;width&quot;:689,&quot;height&quot;:360,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FMOMQUVQLKAZM%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1275,&quot;dateInserted&quot;:&quot;2026-04-10T11:41:39+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FMOMQUVQLKAZM%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/MOMQUVQLKAZM/image.png" alt="image.png" height="360" width="689" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/MOMQUVQLKAZM/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/MOMQUVQLKAZM/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/MOMQUVQLKAZM/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/MOMQUVQLKAZM/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/MOMQUVQLKAZM/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/MOMQUVQLKAZM/image.png 2000w, https://us.v-cdn.net/6038601/uploads/MOMQUVQLKAZM/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 3.</strong> Representative abdominal PVP scans from both a photon-counting detector CT (PCCT) and an energy-integrating detector CT (EID-CT), illustrating comparable image quality (IQ). Image A and B were rated as moderate and image D and E as good by both observers. Image C and F are the 55 keV reconstructions of image B and E respectively but were not assessed subjectively.</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/IODNVI4RRZAW\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:47926,&quot;width&quot;:656,&quot;height&quot;:394,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FIODNVI4RRZAW%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1276,&quot;dateInserted&quot;:&quot;2026-04-10T11:47:53+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FIODNVI4RRZAW%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/IODNVI4RRZAW/image.png" alt="image.png" height="394" width="656" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/IODNVI4RRZAW/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/IODNVI4RRZAW/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/IODNVI4RRZAW/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/IODNVI4RRZAW/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/IODNVI4RRZAW/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/IODNVI4RRZAW/image.png 2000w, https://us.v-cdn.net/6038601/uploads/IODNVI4RRZAW/image.png" sizes="100vw" /></a>
    </span>
</span>
<h3 data-id="protocol">Protocol</h3><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>QuantumPlus</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>120 kV</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.25 for combined thorax/abdominal CT; </p><p>0.5 for abdominal CT only</p></td></tr><tr><td><p><strong>Collimation</strong></p></td><td><p>144 × 0.40 mm</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>145</p><p>optimized for soft tissue with contrast</p></td></tr><tr><td><p><strong>Tube current modulation</strong></p></td><td><p>CARE Dose 4D</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>7.4 ± 2.2</p></td></tr><tr><td><p><strong>Standard reconstruction</strong></p></td><td><p>VMI at 60 keV</p></td></tr><tr><td><p><strong>Secondary reconstruction</strong></p></td><td><p>VMI at 55 keV from spectral post-processing</p></td></tr><tr><td><p><strong>Slice thickness / increment</strong></p></td><td><p>3 mm / 2 mm</p></td></tr><tr><td><p><strong>Kernel</strong></p></td><td><p>Br40</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>Level 3</p></td></tr><tr><td><p><strong>SPP reconstruction thickness / increment</strong></p></td><td><p>2 mm / 1.5 mm</p></td></tr><tr><td><p><strong>SPP kernel</strong></p></td><td><p>Qr40</p></td></tr><tr><td><p><strong>Contrast agent</strong></p></td><td><p>Ultravist 300 mgI/mL or Ultravist 370 mgI/mL</p></td></tr><tr><td><p><strong>Injection access</strong></p></td><td><p>18-, 20-, or 22-gauge needle</p></td></tr><tr><td><p><strong>Scan timing</strong></p></td><td><p>Approximately 70 s after injection</p></td></tr><tr><td><p><strong>Contrast dosing factor</strong></p></td><td><p>0.30 g I/kg</p></td></tr><tr><td><p><strong>Injection duration</strong></p></td><td><p>30 s</p></td></tr><tr><td><p><strong>Protocol basis</strong></p></td><td><p>TBW-adapted CM protocol tailored to VMI at 60 keV</p></td></tr></table></div><p>Hoeijmakers EJI, Stammen L, Wildberger JE, et al. <strong>PCD-CT enables contrast media reduction in abdominal imaging compared to an individualized kV-adapted contrast media injection protocol on EID-CT.</strong> <em>Eur J Radiol.</em> 2024;179:111680.</p>]]>
        </description>
    </item>
    <item>
        <title>(2024) Woeltjen | Low-keV VMI improves conspicuity on PCCT for pancreatic cancer</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/343/2024-woeltjen-low-kev-vmi-improves-conspicuity-on-pcct-for-pancreatic-cancer</link>
        <pubDate>Fri, 10 Apr 2026 11:38:49 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">343@/de/discussions</guid>
        <description><![CDATA[<div><div><p>Mono40 keV images provided the best pancreatic ductal adenocarcinoma conspicuity on PCCT in both arterial and portal venous phases.</p><p></p><p>Quantitatively, tumor-parenchyma attenuation difference and CNR were highest at 40 keV and decreased stepwise with rising keV.</p><p></p><p>Readers still preferred polyenergetic images for overall image quality and lowest perceived noise, despite better lesion conspicuity on low-keV VMI.</p></div></div><p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.ejradiology.com%2Farticle%2FS0720-048X%2824%2900090-1%2Ffulltext" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/SY4HMBZH2EW3\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:280370,&quot;width&quot;:711,&quot;height&quot;:376,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FSY4HMBZH2EW3%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1274,&quot;dateInserted&quot;:&quot;2026-04-10T11:34:28+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FSY4HMBZH2EW3%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/SY4HMBZH2EW3/image.png" alt="image.png" height="376" width="711" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/SY4HMBZH2EW3/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/SY4HMBZH2EW3/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/SY4HMBZH2EW3/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/SY4HMBZH2EW3/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/SY4HMBZH2EW3/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/SY4HMBZH2EW3/image.png 2000w, https://us.v-cdn.net/6038601/uploads/SY4HMBZH2EW3/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 4.</strong> PCCT images of the pancreas with a superior mesenteric artery encasing PDAC in arterial (A–C) and portal venous (D–F) contrast phase. A and D are polyenergetic reconstructions. B and E are monoenergetic reconstructions at 40 keV. C and F are monoenergetic reconstructions at 70 keV.</p><p>Source: Woeltjen et al., <em>European Journal of Radiology</em>, 2024</p><p></p><h3 data-id="protocol">Protocol</h3><p></p><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Value</p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>QuantumPlus</p></td></tr><tr><td><p><strong>Tube voltage [kVp]</strong></p></td><td><p>120–140</p></td></tr><tr><td><p><strong>Slice collimation</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Tube current modulation</strong></p></td><td><p>CARE Dose4D</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>170</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>0.8</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.5</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>8.1 ± 2.5 mGy arterial</p><p>7.7 ± 1.9 mGy portal venous</p></td></tr><tr><td><p><strong>Doselength product [mGy*cm]</strong></p></td><td><p>209.8 ± 78.9 arterial</p><p>443.2 ± 149.5 portal venous</p></td></tr><tr><td><p><strong>Contrast agent</strong></p></td><td><p>ACCUPAQUE 300</p></td></tr><tr><td><p><strong>Contrast dose</strong></p></td><td><p>1 mL/kg</p></td></tr><tr><td><p><strong>Injection flow</strong></p></td><td><p>4 mL/s for initial diagnostic scans; 2.5 mL/s for follow-up venous-only scans</p></td></tr><tr><td><p><strong>Bolus trigger</strong></p></td><td><p>ROI in descending aorta, threshold 100</p></td></tr><tr><td><p><strong>Arterial delay</strong></p></td><td><p>7 s after threshold</p></td></tr><tr><td><p><strong>Venous delay</strong></p></td><td><p>60 s after threshold</p></td></tr><tr><td><p><strong>Post-processing software</strong></p></td><td><p>Syngo.Via VB60</p></td></tr><tr><td><p><strong>VMI range</strong></p></td><td><p>40–70 keV in 5 keV steps</p></td></tr><tr><td><p><strong>Polyenergetic kernel</strong></p></td><td><p>Br36</p></td></tr><tr><td><p><strong>Spectral</strong></p></td><td><p>40 keV images</p></td></tr><tr><td><p><strong>VMI kernel</strong></p></td><td><p>Qr36</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>Quantum iterative reconstruction Q4</p></td></tr><tr><td><p><strong>Slice thickness / increment</strong></p></td><td><p>1.0 mm / 0.6 mm</p></td></tr></table></div><p>Woeltjen MM, Niehoff JH, Roggel R, et al. <strong>Pancreatic cancer in photon-counting CT: Low keV virtual monoenergetic images improve tumor conspicuity.</strong> <em>Eur J Radiol.</em> 2024;173:111374.</p>]]>
        </description>
    </item>
    <item>
        <title>A pancreatic ductal adenocarcinoma with perineural invasion</title>
        <link>https://connect.siemens-healthineers.com/de/discussion/182/a-pancreatic-ductal-adenocarcinoma-with-perineural-invasion</link>
        <pubDate>Wed, 31 Dec 2025 09:00:06 +0000</pubDate>
        <category>Case reports</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">182@/de/discussions</guid>
        <description><![CDATA[<p></p><h3 data-id="jingyi-liu-md-prof-liang-zhu-md-xi-zhao-md-prof-feng-feng-md">Jingyi Liu, MD*; Prof. Liang Zhu, MD*; Xi Zhao, MD**; Prof. Feng Feng, MD*</h3><h4 data-id="department-of-radiology-peking-union-medical-college-beijing-p-r-china-siemens-healthineers-china">* Department of Radiology, Peking Union Medical College, Beijing, P. R. China** Siemens Healthineers, China</h4><h4 data-id="october-24-2025">October 24, 2025</h4><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/7U35MQ2MI8UZ\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:748493,&quot;width&quot;:1920,&quot;height&quot;:1080,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F7U35MQ2MI8UZ%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:723,&quot;dateInserted&quot;:&quot;2025-12-31T08:59:13+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F7U35MQ2MI8UZ%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/7U35MQ2MI8UZ/image.png" alt="image.png" height="1080" width="1920" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/7U35MQ2MI8UZ/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/7U35MQ2MI8UZ/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/7U35MQ2MI8UZ/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/7U35MQ2MI8UZ/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/7U35MQ2MI8UZ/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/7U35MQ2MI8UZ/image.png 2000w, https://us.v-cdn.net/6038601/uploads/7U35MQ2MI8UZ/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fmarketing.webassets.siemens-healthineers.com%2Fc21efbabcf54f22c%2Fe2265ef7c824%2Fsiemens-healthineers_DI-CT_PancreasCa-Alpha_PUMC.pdf" rel="nofollow noopener ugc" role="button">Download pdf</a> </p><p></p><h3 data-id="history">History</h3><p>A 47-year-old male patient, complaining of persistent upper abdominal pain for the past month, presented himself to the hospital for a check-up. An initial contrast-enhanced CT examination was performed on a conventional energy-integrating detector (EID) CT. This revealed an ill-defined hypo-enhancing mass in the pancreatic body, accompanied by distal pancreatic atrophy, dilation of the main pancreatic duct, splenic vein occlusion and collateral vessel formation. Two critical diagnostic concerns emerged: (1) heterogeneous attenuation within the adjacent main pancreatic duct raising suspicion of an intraductal tumor spread; (2) a ~5 mm hypoattenuating lesion in the hepatic segment IV, exhibiting indistinct margins and equivocal enhancement, raised concerns about a potential metastasis. With informed consent, another contrast-enhanced CT scan was performed three weeks later using an ultra-high resolution (UHR) mode with a photon-counting detector (PCD) CT, NAEOTOM Alpha, for further evaluation.</p><p></p><h3 data-id="diagnosis">Diagnosis</h3><p>Virtual monoenergetic images (VMI), displayed at 50 keV, revealed a distinctly delineated tumor with clear margins (39 × 24 mm in axial plane; 24 mm height in coronal view) in the pancreatic body, causing notably encasement of the splenic artery and occlusion of the splenic vein. Thickening and enhancement of the left celiac ganglion, not shown in previous EID CT, were seen as suspicious of a metastasis. Both prior imaging ambiguities were clearly resolved – the fluid attenuation within the main pancreatic duct was homogeneous, therefore ruling out intraductal tumor spread, and the hepatic lesion in segment IV was non-enhancing with a sharp delineation characterizing a cyst. A pancreatic ductal adenocarcinoma with perineural invasion (metastasis of the left celiac ganglion) was suggested and subsequently confirmed by pathological analysis after a successful radical distal pancreatectomy with splenectomy and a partial portal vein reconstruction. The patient recovered uneventfully.</p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/J61Z9Y7YIRUF\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1054680,&quot;width&quot;:1920,&quot;height&quot;:1080,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJ61Z9Y7YIRUF%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:724,&quot;dateInserted&quot;:&quot;2025-12-31T08:59:43+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJ61Z9Y7YIRUF%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/J61Z9Y7YIRUF/image.png" alt="image.png" height="1080" width="1920" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/J61Z9Y7YIRUF/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/J61Z9Y7YIRUF/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/J61Z9Y7YIRUF/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/J61Z9Y7YIRUF/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/J61Z9Y7YIRUF/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/J61Z9Y7YIRUF/image.png 2000w, https://us.v-cdn.net/6038601/uploads/J61Z9Y7YIRUF/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><em>Fig. 1: Axial images acquired during the arterial (Figs. 1a &amp; 1b, EID at 1 mm, PCD at 0.4 mm) and venous phases (Figs. 1c &amp; 1d, 3 mm) show a comparison of CT findings in the pancreas in EID (Figs. 1a &amp; 1c) and PCD CT images (Figs. 1b &amp; 1d). The fluid attenuation within the main pancreatic duct (arrows) adjacent to the tumor appears heterogeneous in EID CT images, however, clearly homogeneous in PCD CT images, ruling out the suspicion of an intraductal tumor spread. The tumor is distinctly delineated with clear margins in the PCD CT images (dotted arrows). Note the improved contrast in PCD CT images using VMIs displayed at 50 keV. </em></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/ALTF1MU72PAF\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1018954,&quot;width&quot;:1920,&quot;height&quot;:1080,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FALTF1MU72PAF%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:725,&quot;dateInserted&quot;:&quot;2025-12-31T08:59:45+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FALTF1MU72PAF%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/ALTF1MU72PAF/image.png" alt="image.png" height="1080" width="1920" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/ALTF1MU72PAF/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/ALTF1MU72PAF/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/ALTF1MU72PAF/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/ALTF1MU72PAF/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/ALTF1MU72PAF/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/ALTF1MU72PAF/image.png 2000w, https://us.v-cdn.net/6038601/uploads/ALTF1MU72PAF/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><em>Fig. 2: A hypoattenuating lesion in the hepatic segment IV, exhibiting indistinct margins and equivocal enhancement in an EID CT image (Fig. 2a, arrow), is clearly characterized as a non-enhancing, sharply delineated cyst in a PCD CT image (Fig. 2b, arrow). Both images are reconstructed at 1 mm, displayed at same window settings. The image noise is notably less in the PCD CT image.</em></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/G38SDV6HOLME\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1108378,&quot;width&quot;:1920,&quot;height&quot;:1080,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FG38SDV6HOLME%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:726,&quot;dateInserted&quot;:&quot;2025-12-31T08:59:49+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FG38SDV6HOLME%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/G38SDV6HOLME/image.png" alt="image.png" height="1080" width="1920" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/G38SDV6HOLME/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/G38SDV6HOLME/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/G38SDV6HOLME/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/G38SDV6HOLME/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/G38SDV6HOLME/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/G38SDV6HOLME/image.png 2000w, https://us.v-cdn.net/6038601/uploads/G38SDV6HOLME/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><em>Fig. 3: Thickening and enhancement of the left celiac ganglion, not shown in an EID CT image (Fig. 3a, arrow, 1 mm), is clearly seen in a PCD CT image (Fig. 3b, arrow, 0.4 mm), indicating a metastasis. It is also confirmed by pathological analysis after surgery. Both images are displayed at same window settings. Note the improved contrast in the PCD CT image using a VMI displayed at 50 keV. </em></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/KM5L8HQK6BVL\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:2434492,&quot;width&quot;:1920,&quot;height&quot;:1080,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FKM5L8HQK6BVL%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:727,&quot;dateInserted&quot;:&quot;2025-12-31T09:00:00+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/de/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FKM5L8HQK6BVL%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/KM5L8HQK6BVL/image.png" alt="image.png" height="1080" width="1920" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/KM5L8HQK6BVL/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/KM5L8HQK6BVL/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/KM5L8HQK6BVL/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/KM5L8HQK6BVL/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/KM5L8HQK6BVL/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/KM5L8HQK6BVL/image.png 2000w, https://us.v-cdn.net/6038601/uploads/KM5L8HQK6BVL/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><em>Fig. 4: cVRT images show a distinctly delineated tumor in the pancreatic body (Fig. 4a, arrow), causing notably encasement of the splenic artery (Fig. 4c, arrow), and occlusion of the splenic vein (Fig. 4d, arrow). The left celiac ganglion (Fig. 4b, arrow), thickened and enhanced, is confirmed as a metastasis by pathological analysis after surgery. Images reconstructed at 0.2 mm with a sharp kernel of Bv48 are used to create these cVRT images.</em></p><p></p><h3 data-id="comments">Comments</h3><p>Accurate preoperative imaging is crucial in pancreatic cancer, yet conventional EID CT often struggles to delineate tumor boundaries and assess adjacent structures – particularly in hypo- or isoattenuating lesions – leading to potential misjudgments in resectability. [1]</p><p>PCD CT offers significant technical advances, including improved spatial resolution, reduced image noise and intrinsic spectral imaging. [2,3] These features enhance tumor conspicuity and allow improved visualization of both vascular and neural invasion. Emerging evidence has suggested that PCD CT outperforms conventional EID CT in abdominal imaging, supporting its growing value in preoperative assessment and surgical planning. [4,5].</p><p>In this case, these advantages translated into clear clinical impact – PCD CT not only improved tumor conspicuity and delineation of peripancreatic neural invasion, but also confidently resolved two critical diagnostic ambiguities: the suspected intraductal tumor spread and the potential hepatic metastasis, either of which could have altered surgical management.</p><p>These benefits were achieved through the use of an UHR scan mode, in which small sub-pixels are defined by electric fields rather than physical separations and are read out separately to increase the spatial resolution with improved geometrical dose efficiency of the detector. Simultaneously, spectral information was acquired, allowing for increased image contrast by displaying VMI at low keV (50 keV in this case). This unique combination provides improved image sharpness and contrast-to-noise ratio, helping the characterization of small lesions and anatomical details, especially in soft tissue. These UHR images are also optimized for in-depth three-dimensional image rendering, using cinematic volume rendering technique (cVRT), facilitating communication with the clinicians. It is also worth noting that a Flash mode (pitch of 2.35) with a collimation of 96 x 0.2 mm is performed to achieve a fast acquisition of the arterial phase (2.8 s), using the advantage of dual source CT scanning, further improving the visualization of vascular details.</p><p>This case highlights how the combination of ultra-high spatial resolution with low-keV spectral imaging can translate into actionable diagnostic confidence, enabling not only accurate local staging in pancreatic cancer but also better-informed surgical strategies through enhanced visualization of critical anatomical details.</p><p></p><h3 data-id="examination-protocol">Examination Protocol</h3><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Scanner</strong></p></th><th><p>NAEOTOM Alpha </p></th></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Abdomen (Arterial / Venous phase)</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>UHR (Quantumplus, Flash mode / Quantumplus)</p></td></tr><tr><td><p><strong>Scan length</strong></p></td><td><p>507.6 mm</p></td></tr><tr><td><p><strong>Scan direction</strong></p></td><td><p>Cranio-caudal</p></td></tr><tr><td><p><strong>Scan time</strong></p></td><td><p>2.8 / 7.0 s</p></td></tr><tr><td><p><strong>Tube voltage</strong></p></td><td><p>120 kV</p></td></tr><tr><td><p><strong>Effective mAs</strong></p></td><td><p>158 / 123 mAs</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>220</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>CARE Dose4D</p></td></tr><tr><td><p><strong>CTDIvol</strong></p></td><td><p>12.9 / 9.8 mGy</p></td></tr><tr><td><p><strong>DLP</strong></p></td><td><p>671 / 513 mGy*cm</p></td></tr><tr><td><p><strong>Rotation time</strong></p></td><td><p>0.25 s</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>2.35 / 0.75</p></td></tr><tr><td><p><strong>Slice collimation</strong></p></td><td><p>96 × 0.2 / 120 × 0.2 mm</p></td></tr><tr><td><p><strong>Slice width</strong></p></td><td><p>0.2 / 0.4 mm</p></td></tr><tr><td><p><strong>Reconstruction increment</strong></p></td><td><p>0.2 mm</p></td></tr><tr><td><p><strong>Reconstruction kernel</strong></p></td><td><p>Br44 / Bv44 / Bv48 / Qr48</p></td></tr><tr><td><p><strong>keV level</strong></p></td><td><p>50 keV, QIR 3</p></td></tr><tr><td><p><strong>Spectral reconstruction</strong></p></td><td><p>VMI</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>370 mg/mL</p></td></tr><tr><td><p><strong>Volume</strong></p></td><td><p>84 mL + 20 mL saline</p></td></tr><tr><td><p><strong>Flow rate</strong></p></td><td><p>4 mL/s</p></td></tr><tr><td><p><strong>Start delay</strong></p></td><td><p>1. Arterial phase:Bolus tracking triggered at 100 HU in the abdominal aorta + 10 s2. Venous phase:32 s after the arterial phase</p></td></tr></table></div><p>Images: Courtesy of Department of Radiology, Peking Union Medical College, Beijing, P. R. China</p>]]>
        </description>
    </item>
   </channel>
</rss>
